hydralazine has been researched along with Pregnancy in 316 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objectives were to compare the efficacy and safety of intravenous hydralazine and labetalol for acutely lowering severe hypertension in pregnancy." | 9.51 | Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial. ( Bako, B; Dawha, YM; Muhammad, S; Usman, H; Yahya, A; Yekeen, A, 2022) |
| "We sought to compare the efficacy of intravenously administered hydralazine and oral nifedipine for acute blood pressure control in acute hypertensive emergency of pregnancy." | 9.24 | Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. ( Gupta, A; Sharma, C; Soni, A; Verma, A; Verma, S, 2017) |
| "This network meta-analysis aimed to compare the efficacy and safety of intravenous (IV) hydralazine, oral nifedipine, and IV labetalol with different dosage regimens in the treatment of severe hypertension during pregnancy." | 9.22 | Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials. ( Cheng, Y; Jiang, YF; Li, JB; Wu, HZ; Yu, D; Zhu, ZN, 2022) |
| "We evaluated 16 pregnant women with gestational age between 20 and 32 weeks in acute severe hypertension which were randomly allocated to receive either hydralazine or labetalol." | 9.15 | Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. ( Baggio, MR; Berezowski, AT; Calderon, AC; Cavalli, RC; Duarte, G; Marcolin, AC; Martins, WP, 2011) |
| "Intravenous hydralazine is a commonly administered arteriolar vasodilator that is effective for hypertensive emergencies associated with pregnancy." | 9.15 | Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy. ( Esmaeili, S; Khazaeipour, Z; Motevalian, M; Pourmojieb, M; Rezaei, Z; Sharbaf, FR; Youefzadeh-Fard, Y, 2011) |
| "Diazoxide is one of few available agents for treatment of hypertensive emergencies in pregnancy." | 9.12 | A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. ( Child, A; Gillin, AG; Henderson-Smart, DJ; Hennessy, A; Makris, A; Ogle, RF; Thornton, CE, 2007) |
| "Nifedipine is safe and more effective than hydralazine in controlling blood pressure in severe pre-eclampsia." | 9.10 | Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia. ( Aali, BS; Nejad, SS, 2002) |
| "Although hydralazine has been the drug of choice for treating pregnancy-induced hypertension for some time owing to its effect on peripheral vascular tonus, its effects on utero- and feto-placental circulation are less well understood." | 9.08 | Effects of hydralazine on placental and renal circulation in pre-eclampsia. ( Gennser, G; Gudmundsson, S; Marsal, K, 1995) |
| "To compare ketanserin with hydralazine in the treatment of hypertension in late pregnancy." | 9.08 | Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial. ( Howarth, G; Odendaal, HJ; Rossouw, HJ, 1995) |
| "The purposes of this study were to compare the efficacy of sublingual nifedipine with intravenous hydrallazine in the control of acute hypertension of pregnancy and to make a preliminary assessment whether sublingual nifedipine could be recommended for use by midwives faced with severe hypertension in pregnancy in a rural setting." | 9.08 | Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. ( Jegasothy, R; Paranthaman, S, 1996) |
| "The objective was to compare the fetal and maternal effects between parenteral hydralazine and sublingual nifedipine used like antihypertensive drugs in the management of severe preeclampsia." | 9.07 | [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents]. ( Flores Padilla, LM; Walss Rodriguez, RJ, 1993) |
| "Labetalol (Trandate; Allen & Hanburys), a combined alpha- and beta-adrenergic blocking agent, was compared with the more commonly used peripheral vasodilator, dihydrallazine (Nepresol; Ciba), each administered as an infusion, in the treatment of severe hypertension in 20 primigravidas at greater than or equal to 32 weeks' gestation." | 9.06 | Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. ( Ashe, RG; Moodley, J; Philpott, RH; Richards, AM, 1987) |
| "Forty-four consecutive patients referred for treatment because of hypertension (greater than 150/90 mmHg) occurring during pregnancy were randomly allocated to one of two treatment groups, hydralazine alone (n = 21) or hydralazine combined with pindolol (n = 23)." | 9.06 | Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. ( Boner, G; Bott-Kanner, G; Friedman, S; Merlob, P; Nissenkorn, A; Ovadia, J; Paran, E; Reisner, S; Rosenfeld, J; Zmora, E, 1986) |
| "Patients with acute pregnancy-related hypertension were randomized to treatment with 200 mg oral labetalol or 10 mg intramuscular hydralazine." | 9.05 | Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared. ( Calder, AA; Greer, I; Walker, JJ, 1983) |
| "The effect of intravenous infusion of labetalol and of dihydralazine in increasing doses was compared in 12 women with severe hypertension in pregnancy." | 9.05 | Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. ( Davey, DA; Dommisse, J; Garden, A, 1982) |
| "Twentysix women with pregnancy-induced hypertension have been randomly treated with either labetalol or Aldomet." | 9.05 | Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. ( Broughton Pipkin, F; Lamming, GD; Symonds, EM, 1980) |
| "In an open, controlled trial, treatment with a combination of metoprolol and hydralazine was compared with non-pharmacological management of mild and moderate hypertension in pregnancy." | 9.05 | A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. ( Axelsson, O; Högstedt, S; Lindberg, BS; Lindeberg, S; Lindmark, G; Rane, A; Sandström, B, 1985) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 9.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| " Plasma renin activity (PRA), the daily urinary excretion of aldosterone (dU-Aldo) and electrolytes were studied before and during dihydralazine therapy (25 mg 3 times daily)." | 9.04 | The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy. ( Lammintausta, R, 1978) |
| "To review outcomes in randomised controlled trials comparing hydralazine against other antihypertensives for severe hypertension in pregnancy." | 8.82 | Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. ( Cham, C; Magee, LA; Ohlsson, A; von Dadelszen, P; Waterman, EJ, 2003) |
| "Tradiational drug therapy choices for hypertension in pregnancy continue to be hydralazine for acute reduction of blood pressure and methyldopa for the management of chronic hypertension." | 8.79 | Use of nifedipine in the hypertensive diseases of pregnancy. ( Doering, PL; Hatton, RC; Levin, AC, 1994) |
| "To compare the efficacy of intravenous Labetalol and intravenous Hydralazine in reduction of blood pressure in patients with severe pre-eclampsia." | 8.31 | Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women. ( Husain, S; Hussain, R; Kausar, M, 2023) |
| "Gestational hydralazine reduced renal global DNA methylation in offspring of obese mothers and attenuated maternal obesity-induced renal fibrosis." | 8.02 | Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet. ( Chen, H; Glastras, SJ; Hou, M; Larkin, BP; Nguyen, LT; Pollock, CA; Saad, S; Wang, R, 2021) |
| "Hydralazine, an antihypertensive agent used during pregnancy, undergoes N-acetylation primarily via N-acetyltransferase 2 (NAT2) to form 3-methyl-1,2,4-triazolo[3,4-a]phthalazine (MTP)." | 7.91 | Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy. ( Cusumano, M; Easterling, TR; Han, LW; Hebert, MF; Phillips, BR; Risler, LJ; Ryu, RJ; Shen, DD, 2019) |
| "We describe a novel ER+ breast cancer model to study de novo and acquired tamoxifen (TAM) resistance." | 7.85 | Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model. ( Bouker, KB; Clarke, R; Cook, KL; Cruz, MI; de Assis, S; Hilakivi-Clarke, L; Hu, R; Jin, L; Nguyen, N; Wang, X; Wang, Y; Wärri, A; Wehrenberg, B; Xuan, J; Zhang, X; Zwart, A, 2017) |
| "Antihypertensive drugs such as clonidine, diazoxide, hydralazine and furosemide are used in the hypertensive disorders of pregnancy to control blood pressure, but it is not clear if they modulate the production of placental or circulating cytokines." | 7.73 | Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy. ( Hennessy, A; Horvath, JS; Makris, A; Ogle, R; Thornton, C; Xu, B, 2006) |
| "To audit the use of bolus hydralazine for control of severe hypertension within a protocol for the management of severe pre-eclampsia." | 7.69 | Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia. ( de Swiet, M; Paterson-Brown, S; Redfern, N; Robson, SC; Walkinshaw, SA, 1994) |
| " Cyclic GMP concentrations were also determined in 12 women with severe pre-eclampsia before and after treatment with hydralazine." | 7.69 | Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: effects of hydralazine. ( Calle, A; Jácome, P; López-Jaramillo, P; Narváez, M; Nava, E; Rivera, J; Ruano, C, 1996) |
| " This study was undertaken in gravid ewes to determine the effects of treatment of cocaine-induced hypertension with hydralazine (Apresoline) on the maternal and fetal cardiovascular systems, catecholamine response, blood gas and acid-base status, and uterine blood flow (UBF)." | 7.68 | Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe. ( Espinoza, MI; Hughes, SC; Johnson, JL; Messer, CP; Parer, JT; Rosen, MA; Shnider, SM; Vertommen, JD, 1992) |
| "Acute cocaine intoxication has been associated with elevated blood pressure and placental abruption." | 7.68 | Cocaine intoxication associated with abruptio placentae. ( Clark, JF; Flowers, D; Westney, LS, 1991) |
| " The mother suffered from lupus-like syndrome consequent to hydralazine treatment for pregnancy-induced hypertension." | 7.67 | Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report. ( Bar-Khayim, Y; Dgani, R; Lancet, M; Mogilner, BM; Nissim, F; Shoham, Z; Yemini, M, 1989) |
| "The apex cardiogram and its 1st differential quotient were simultaneously registered with the phonocardiogram, the electrocardiogram and the curve of the carotid pulse in 10 female patients with pregnancy-induced hypertension before and after the therapy with dihydralazine sulphate." | 7.67 | [Studies of heart function using apex cardiography in pregnancy-induced hypertension before and following therapy with dihydralazine sulfate]. ( Benndorf, S; Kehrbein, C; Nahrendorf, W; Rading, A; Steinig, G; Weidler, B, 1986) |
| "The hemodynamic changes after intravenous administration of hydralazine were assessed using M-mode echocardiography in 13 pregnant patients with severe hypertension." | 7.67 | Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension. ( Kuzniar, J; Piela, A; Skret, A; Szmigiel, Z; Zaczek, T, 1985) |
| "The uteroplacental blood flow was measured in 12 women with hypertension during pregnancy before and after intravenous injection of dihydralazine." | 7.66 | Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. ( Lewander, R; Lunell, NO; Nylund, L; Sarby, B; Thornström, S, 1983) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 7.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| "Hydralazine was found to be superior in its ability to effect more rapidly a lower mean arterial blood pressure." | 6.66 | Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension. ( Griffis, KR; Martin, JN; Martin, RW; Morrison, JC; Palmer, SM, 1989) |
| " The duration of action also varied in the labetalol group, with the shortest duration occurring in those patients who required the highest dosage for BP control." | 6.66 | A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. ( Amon, E; Gonzalez, AR; Mabie, WC; Sibai, BM, 1987) |
| "Magnesium sulfate was promptly administered on admission to every woman to prevent seizure." | 5.56 | Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women. ( Chera-Aree, P; Leetheeragul, J; Sampaojarean, U; Surasereewong, S; Tengtrakulcharoen, P; Wataganara, T, 2020) |
| "The objectives were to compare the efficacy and safety of intravenous hydralazine and labetalol for acutely lowering severe hypertension in pregnancy." | 5.51 | Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial. ( Bako, B; Dawha, YM; Muhammad, S; Usman, H; Yahya, A; Yekeen, A, 2022) |
| " Experimental data suggests that hydralazine, given concomitantly, attenuates the development of hemodynamic tolerance to ISDN and may increase bioavailability of NO in the vasculature." | 5.35 | Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure. ( Jacob, RG; Thadani, U, 2008) |
| "Twenty mothers with moderate to severe preeclampsia were allocated to labetalol (Trandate) or hydralazine (Apresolin) antihypertensive treatment." | 5.29 | Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment. ( Faxelius, G; Hjertberg, R; Lagercrantz, H, 1993) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 5.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| "We sought to compare the efficacy of intravenously administered hydralazine and oral nifedipine for acute blood pressure control in acute hypertensive emergency of pregnancy." | 5.24 | Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. ( Gupta, A; Sharma, C; Soni, A; Verma, A; Verma, S, 2017) |
| "This network meta-analysis aimed to compare the efficacy and safety of intravenous (IV) hydralazine, oral nifedipine, and IV labetalol with different dosage regimens in the treatment of severe hypertension during pregnancy." | 5.22 | Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials. ( Cheng, Y; Jiang, YF; Li, JB; Wu, HZ; Yu, D; Zhu, ZN, 2022) |
| "Hydralazine is a vasodilator used to treat hypertension, pre-eclampsia, and heart failure." | 5.22 | A review on the clinical pharmacokinetics of hydralazine. ( Alqahtani, F; Ashraf, W; Hussain, I; Imran, I; Khalid, S; Majeed, A; Rasool, MF; Rehman, AU; Saeed, H; Shahzad Qamar, A; Zamir, A, 2022) |
| "We evaluated 16 pregnant women with gestational age between 20 and 32 weeks in acute severe hypertension which were randomly allocated to receive either hydralazine or labetalol." | 5.15 | Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. ( Baggio, MR; Berezowski, AT; Calderon, AC; Cavalli, RC; Duarte, G; Marcolin, AC; Martins, WP, 2011) |
| "Intravenous hydralazine is a commonly administered arteriolar vasodilator that is effective for hypertensive emergencies associated with pregnancy." | 5.15 | Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy. ( Esmaeili, S; Khazaeipour, Z; Motevalian, M; Pourmojieb, M; Rezaei, Z; Sharbaf, FR; Youefzadeh-Fard, Y, 2011) |
| "Diazoxide is one of few available agents for treatment of hypertensive emergencies in pregnancy." | 5.12 | A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. ( Child, A; Gillin, AG; Henderson-Smart, DJ; Hennessy, A; Makris, A; Ogle, RF; Thornton, CE, 2007) |
| "Nifedipine is safe and more effective than hydralazine in controlling blood pressure in severe pre-eclampsia." | 5.10 | Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia. ( Aali, BS; Nejad, SS, 2002) |
| "Although hydralazine has been the drug of choice for treating pregnancy-induced hypertension for some time owing to its effect on peripheral vascular tonus, its effects on utero- and feto-placental circulation are less well understood." | 5.08 | Effects of hydralazine on placental and renal circulation in pre-eclampsia. ( Gennser, G; Gudmundsson, S; Marsal, K, 1995) |
| "To compare ketanserin with hydralazine in the treatment of hypertension in late pregnancy." | 5.08 | Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial. ( Howarth, G; Odendaal, HJ; Rossouw, HJ, 1995) |
| "Fifty-one women with pregnancy-induced hypertension (PIH) were randomly allocated to one of three treatment groups: A: hydralazine (13); B: hydralazine and propranolol (17); and C: hydralazine and pindolol (19)." | 5.08 | Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. ( Holzberg, G; Insler, V; Mazor, M; Paran, E; Zmora, E, 1995) |
| "The purposes of this study were to compare the efficacy of sublingual nifedipine with intravenous hydrallazine in the control of acute hypertension of pregnancy and to make a preliminary assessment whether sublingual nifedipine could be recommended for use by midwives faced with severe hypertension in pregnancy in a rural setting." | 5.08 | Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. ( Jegasothy, R; Paranthaman, S, 1996) |
| "The objective was to compare the fetal and maternal effects between parenteral hydralazine and sublingual nifedipine used like antihypertensive drugs in the management of severe preeclampsia." | 5.07 | [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents]. ( Flores Padilla, LM; Walss Rodriguez, RJ, 1993) |
| "Labetalol (Trandate; Allen & Hanburys), a combined alpha- and beta-adrenergic blocking agent, was compared with the more commonly used peripheral vasodilator, dihydrallazine (Nepresol; Ciba), each administered as an infusion, in the treatment of severe hypertension in 20 primigravidas at greater than or equal to 32 weeks' gestation." | 5.06 | Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. ( Ashe, RG; Moodley, J; Philpott, RH; Richards, AM, 1987) |
| "Forty-four consecutive patients referred for treatment because of hypertension (greater than 150/90 mmHg) occurring during pregnancy were randomly allocated to one of two treatment groups, hydralazine alone (n = 21) or hydralazine combined with pindolol (n = 23)." | 5.06 | Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. ( Boner, G; Bott-Kanner, G; Friedman, S; Merlob, P; Nissenkorn, A; Ovadia, J; Paran, E; Reisner, S; Rosenfeld, J; Zmora, E, 1986) |
| "Patients with acute pregnancy-related hypertension were randomized to treatment with 200 mg oral labetalol or 10 mg intramuscular hydralazine." | 5.05 | Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared. ( Calder, AA; Greer, I; Walker, JJ, 1983) |
| "The effect of intravenous infusion of labetalol and of dihydralazine in increasing doses was compared in 12 women with severe hypertension in pregnancy." | 5.05 | Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. ( Davey, DA; Dommisse, J; Garden, A, 1982) |
| "Twentysix women with pregnancy-induced hypertension have been randomly treated with either labetalol or Aldomet." | 5.05 | Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. ( Broughton Pipkin, F; Lamming, GD; Symonds, EM, 1980) |
| "In an open, controlled trial, treatment with a combination of metoprolol and hydralazine was compared with non-pharmacological management of mild and moderate hypertension in pregnancy." | 5.05 | A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. ( Axelsson, O; Högstedt, S; Lindberg, BS; Lindeberg, S; Lindmark, G; Rane, A; Sandström, B, 1985) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 5.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| " Plasma renin activity (PRA), the daily urinary excretion of aldosterone (dU-Aldo) and electrolytes were studied before and during dihydralazine therapy (25 mg 3 times daily)." | 5.04 | The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy. ( Lammintausta, R, 1978) |
| " Oral nifedipine is now considered an alternative first-line therapy, along with intravenous hydralazine and labetalol for women presenting with pre-eclampsia." | 4.98 | Focused Update on Pharmacologic Management of Hypertensive Emergencies. ( Broscious, R; Devabhakthuni, S; Noel, ZR; Watson, K, 2018) |
| "The present evidence suggests similar efficacy between nifedipine, hydralazine and labetalol in the treatment of severe hypertension in pregnancy." | 4.98 | Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. ( Sequeira, RP; Sridharan, K, 2018) |
| "Oral nifedipine, and possibly labetalol and methyldopa, are suitable options for treatment of severe hypertension in pregnancy/postpartum." | 4.90 | Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. ( Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P, 2014) |
| "To review outcomes in randomised controlled trials comparing hydralazine against other antihypertensives for severe hypertension in pregnancy." | 4.82 | Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. ( Cham, C; Magee, LA; Ohlsson, A; von Dadelszen, P; Waterman, EJ, 2003) |
| "Tradiational drug therapy choices for hypertension in pregnancy continue to be hydralazine for acute reduction of blood pressure and methyldopa for the management of chronic hypertension." | 4.79 | Use of nifedipine in the hypertensive diseases of pregnancy. ( Doering, PL; Hatton, RC; Levin, AC, 1994) |
| " It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia." | 4.76 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984) |
| "To compare the efficacy of intravenous Labetalol and intravenous Hydralazine in reduction of blood pressure in patients with severe pre-eclampsia." | 4.31 | Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women. ( Husain, S; Hussain, R; Kausar, M, 2023) |
| "A retrospective cohort study of patients with severe peripartum hypertension (systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 110 mm Hg confirmed within 15 min) to determine whether the effectiveness of blood pressure control using nationally recommended medications (hydralazine, labetalol, nifedipine) differed by race/ethnicity." | 4.12 | Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension. ( Greene, NH; Kilpatrick, SJ; Pon, FF, 2022) |
| "Gestational hydralazine reduced renal global DNA methylation in offspring of obese mothers and attenuated maternal obesity-induced renal fibrosis." | 4.02 | Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet. ( Chen, H; Glastras, SJ; Hou, M; Larkin, BP; Nguyen, LT; Pollock, CA; Saad, S; Wang, R, 2021) |
| " The American College of Obstetricians and Gynecologists recommends that acute-onset, severe hypertension be treated with first line-therapy (intravenous labetalol, intravenous hydralazine or oral nifedipine) within 60 minutes to reduce risk of maternal morbidity and death." | 3.96 | Identification of factors associated with delayed treatment of obstetric hypertensive emergencies. ( Akerman, MB; Elsayad, A; Halpern, TA; Heiselman, CJ; Heo, HJ; Kantorowska, A; Muscat, JC; Sicuranza, GB; Vintzileos, AM, 2020) |
| "We describe a novel ER+ breast cancer model to study de novo and acquired tamoxifen (TAM) resistance." | 3.85 | Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model. ( Bouker, KB; Clarke, R; Cook, KL; Cruz, MI; de Assis, S; Hilakivi-Clarke, L; Hu, R; Jin, L; Nguyen, N; Wang, X; Wang, Y; Wärri, A; Wehrenberg, B; Xuan, J; Zhang, X; Zwart, A, 2017) |
| "To determine whether the incidence of hypotension or adverse fetal heart tracing (FHT) category change differed following antepartum administration of intravenous (IV) labetalol versus hydralazine." | 3.83 | Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low. ( Aghajanian, P; Greene, N; Kilpatrick, SJ; Rodriguez, M; Sharma, KJ, 2016) |
| " Given her undifferentiated headache and the possibility of preeclampsia, the patient was treated with magnesium sulfate, which was subsequently stopped due to worsening bradycardia." | 3.81 | Late Postpartum Eclampsia with Postpartum Angiopathy: An Uncommon Diagnosis in the Emergency Department. ( Dickman, E; Garg, D; Rahaman, B; Stein, EG, 2015) |
| "We studied the effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam (a dopamine D1-agonist) on isolated human umbilical arteries (HUA) from patients classified as normotensive and with pregnancy-induced hypertension (PIH)." | 3.72 | The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery. ( Arias, ME; Levy, JH; Sato, N; Szlam, F; Tanaka, KA; Tsuda, A, 2003) |
| "These findings demonstrate that agents commonly used for the treatment of hypertensive disease in pregnancy, excluding alpha-methyldopa, have significant direct effects on the feto-placental circulation." | 3.72 | Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance. ( Dennedy, MC; Houlihan, DD; Morrison, JJ; Ravikumar, N, 2004) |
| " With the exception of one subject, all pre-eclamptics were taking clonidine (a known suppressant of rapid eye movement-REM-sleep) for control of their hypertension." | 3.70 | Pre-eclampsia is associated with marked alterations in sleep architecture. ( Blyton, CM; Edwards, N; Kesby, GJ; Sullivan, CE; Wilcox, I, 2000) |
| "To audit the use of bolus hydralazine for control of severe hypertension within a protocol for the management of severe pre-eclampsia." | 3.69 | Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia. ( de Swiet, M; Paterson-Brown, S; Redfern, N; Robson, SC; Walkinshaw, SA, 1994) |
| " Cyclic GMP concentrations were also determined in 12 women with severe pre-eclampsia before and after treatment with hydralazine." | 3.69 | Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: effects of hydralazine. ( Calle, A; Jácome, P; López-Jaramillo, P; Narváez, M; Nava, E; Rivera, J; Ruano, C, 1996) |
| " This study was undertaken in gravid ewes to determine the effects of treatment of cocaine-induced hypertension with hydralazine (Apresoline) on the maternal and fetal cardiovascular systems, catecholamine response, blood gas and acid-base status, and uterine blood flow (UBF)." | 3.68 | Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe. ( Espinoza, MI; Hughes, SC; Johnson, JL; Messer, CP; Parer, JT; Rosen, MA; Shnider, SM; Vertommen, JD, 1992) |
| "Acute cocaine intoxication has been associated with elevated blood pressure and placental abruption." | 3.68 | Cocaine intoxication associated with abruptio placentae. ( Clark, JF; Flowers, D; Westney, LS, 1991) |
| " The mother suffered from lupus-like syndrome consequent to hydralazine treatment for pregnancy-induced hypertension." | 3.67 | Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report. ( Bar-Khayim, Y; Dgani, R; Lancet, M; Mogilner, BM; Nissim, F; Shoham, Z; Yemini, M, 1989) |
| "Echocardiography documented fetal premature atrial contractions after maternal hydralazine treatment for hypertension." | 3.67 | Fetal premature atrial contractions associated with hydralazine. ( Feinstein, SJ; Lodeiro, JG; Lodeiro, SB, 1989) |
| " To test if these structural changes occur in the absence of raised blood pressure, hydralazine was administered to spontaneously hypertensive rats and normotensive controls prior to and during pregnancy (100 ml/l drinking water), and to the newborn males up to 21 weeks of age (16." | 3.67 | Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. ( Forrest, JB; Lee, RM; Smeda, JS, 1988) |
| "The apex cardiogram and its 1st differential quotient were simultaneously registered with the phonocardiogram, the electrocardiogram and the curve of the carotid pulse in 10 female patients with pregnancy-induced hypertension before and after the therapy with dihydralazine sulphate." | 3.67 | [Studies of heart function using apex cardiography in pregnancy-induced hypertension before and following therapy with dihydralazine sulfate]. ( Benndorf, S; Kehrbein, C; Nahrendorf, W; Rading, A; Steinig, G; Weidler, B, 1986) |
| "The hemodynamic changes after intravenous administration of hydralazine were assessed using M-mode echocardiography in 13 pregnant patients with severe hypertension." | 3.67 | Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension. ( Kuzniar, J; Piela, A; Skret, A; Szmigiel, Z; Zaczek, T, 1985) |
| "The uteroplacental blood flow was measured in 12 women with hypertension during pregnancy before and after intravenous injection of dihydralazine." | 3.66 | Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. ( Lewander, R; Lunell, NO; Nylund, L; Sarby, B; Thornström, S, 1983) |
| "The effects on the fetus of the acute lowering of blood pressure in maternal hypertension with dihydralazine 6." | 3.66 | The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy. ( Moodley, J; Vink, GJ, 1982) |
| "The concentration of "real" and "apparent" (= "real" hydralazine + acid-labile hydrazones) hydralazine in maternal and umbilical plasma obtained at delivery of 6 women treated with hydralazine and atenolol for pregnancy hypertension were measured by gas chromatography." | 3.66 | Transplacental passage and breast milk concentrations of hydralazine. ( Hanson, A; Ingemarsson, I; Liedholm, H; Melander, A; Wåhlin-Boll, E, 1982) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 3.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| "During phenylephrine-induced hypertension in 6 near-term pregnant ewes, nitroprusside rapidly lowered the blood pressure to control values with no accompanying change in uterine blood flow." | 3.65 | Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes. ( Krames, E; Levinson, G; Ring, G; Shnider, SM; Wallis, KL, 1977) |
| "Since 1955 standardized treatment applied uniformly to all cases of eclampsia at Parkland Memorial Hospital has consisted of (1) magnesium sulfate intravenously and intramuscularly to control convulsions, (2) intravenous hydralazine intermittently to lower diastolic blood pressure when it exceeded 110 mm." | 3.65 | Standardized treatment of 154 consecutive cases of eclampsia. ( Pritchard, JA; Pritchard, SA, 1975) |
| "An active approach to the management of severe pre-eclampsia is outlined using sedation with diazepam, hypotensive therapy with hydralazine and immediate steps to terminate the pregnancy." | 3.65 | Active management of severe pre-eclampsia. ( Baskett, TF; Bradford, CR, 1973) |
| "Hydralazine was found to be superior in its ability to effect more rapidly a lower mean arterial blood pressure." | 2.66 | Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension. ( Griffis, KR; Martin, JN; Martin, RW; Morrison, JC; Palmer, SM, 1989) |
| " The duration of action also varied in the labetalol group, with the shortest duration occurring in those patients who required the highest dosage for BP control." | 2.66 | A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. ( Amon, E; Gonzalez, AR; Mabie, WC; Sibai, BM, 1987) |
| "The incidence of neonatal jaundice was higher in the control group (P less than 0." | 2.66 | Lumbar epidural analgesia in hypertensive patients during labour. ( Lachman, E; Neri, A; Nitke, S; Ovadia, J, 1986) |
| "The incidence of preeclampsia in the randomized prophylactic antihypertensive group was statistically lower than that in the nonrandomized group (8." | 2.65 | The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies. ( Crenshaw, MC; Dorminy, JH; Gall, SA; Jelovsek, FR; Welt, SI, 1981) |
| "Preeclampsia is characterized by blood pressure greater than 140/90 mmHg in the second half of pregnancy." | 2.55 | Pathophysiology and Current Clinical Management of Preeclampsia. ( Amaral, LM; LaMarca, B; Owens, M; Wallace, K, 2017) |
| "Risk factors for the development of preeclampsia include microvascular diseases, such as diabetes mellitus; vascular and connective tissue disorders; hypertension; antiphospholipid antibody syndrome; and nephropathy." | 2.45 | Pharmacotherapeutic options for the treatment of preeclampsia. ( Baldwin, K; McCoy, S, 2009) |
| "Marfan syndrome is an inheritable connective tissue disorder with multisystem involvement and variable expression of signs and symptoms, caused by mutations within the fibrillin gene on chromosome 15q21." | 2.43 | Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature. ( Elami, A; Ezra, Y; Gilon, D; Ginosar, Y; Pollak, A; Volach, V, 2006) |
| "Management of preeclampsia is bed rest, aspirin administration, antihypertensive agents (beta-blockers, hydralazine, alpha-methyldopa) would be used for reduction of blood pressure." | 2.40 | [Pregnancy induced hypertension]. ( Suzuki, H, 1997) |
| "Hypertension in pregnancy has implications for both maternal and fetal welfare." | 2.37 | Hypertension in pregnancy. Pathophysiology and management. ( Lubbe, WF, 1984) |
| "Although hypertension is the most common and significant risk factor in pregnancy, the risks can be minimized with careful supervision and therapy." | 2.37 | Hypertension in pregnant women. ( Gallery, ED, 1985) |
| "Hydralazine was administered in daily doses of 50 mg, starting 24-36 h after the initial diagnosis of EUVI and continuing throughout the first trimester." | 1.72 | First-trimester miscarriage rate decreases with hydralazine therapy in pregnancies with early uterine vascular insufficiency: a cohort study. ( Biron, M; Canals, A; Castiglione, A; Faundez, R; Leible, S; Mitelman, G; Sepulveda, W; Walton, R, 2022) |
| "Magnesium sulfate was promptly administered on admission to every woman to prevent seizure." | 1.56 | Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women. ( Chera-Aree, P; Leetheeragul, J; Sampaojarean, U; Surasereewong, S; Tengtrakulcharoen, P; Wataganara, T, 2020) |
| "Heart failure is an established predictor of primary cardiac events during pregnancy." | 1.40 | Treatment of pre-existing cardiomyopathy during pregnancy. ( Ascoop, AK; De Backer, J; De Pauw, M; Gevaert, S; Roelens, K; Tromp, F, 2014) |
| "Postpartum preeclampsia/eclampsia is the presence of hypertension and proteinuria, with or without seizures, occurring up to 4 weeks after delivery." | 1.37 | Postpartum preeclampsia: emergency department presentation and management. ( Abbott, J; Bakes, K; Withers, E; Yancey, LM, 2011) |
| " Experimental data suggests that hydralazine, given concomitantly, attenuates the development of hemodynamic tolerance to ISDN and may increase bioavailability of NO in the vasculature." | 1.35 | Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure. ( Jacob, RG; Thadani, U, 2008) |
| "Mean IL-18 levels were lower in preeclampsia than in controls (185 +/- 74 pg/mL vs 224 +/- 75 pg/mL, P =." | 1.32 | Interleukin-18 in the plasma of women with preeclampsia. ( Adams, KM; Atkinson, MW; Guthrie, KA; Mandel, LS, 2003) |
| "Coincident with the preeclampsia was a postdural puncture headache complicating the diagnosis of late postpartum preeclampsia." | 1.32 | Late postpartum eclampsia coincident with postdural puncture headache: a case report. ( Norman, D; Winston, AW, 2003) |
| "Enalapril treatment resulted in a 24% mortality, reduced body weight, and decreased heart weight (p < 0." | 1.31 | Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. ( Cheon, HW; Choi, JH; Hong, YS; Kim, CH; Kim, KB; Kim, SK; Lee, JW; Yoo, KH, 2002) |
| "3 U/MPL), mild preeclampsia (6." | 1.30 | Anticardiolipin antibodies and the severity of preeclampsia-eclampsia. ( Cortés-Llamas, V; González-Ortiz, M; Martínez-Abundis, E; Salazar-Páramo, M, 1999) |
| "Twenty mothers with moderate to severe preeclampsia were allocated to labetalol (Trandate) or hydralazine (Apresolin) antihypertensive treatment." | 1.29 | Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment. ( Faxelius, G; Hjertberg, R; Lagercrantz, H, 1993) |
| "We present a case of acute renal failure due to severe preeclampsia successfully treated with the infusion of a low dose of dopamine." | 1.29 | Low-dose dopamine in treating acute renal failure caused by preeclampsia. ( Anai, T; Miyakawa, I; Nasu, K; Yoshimatsu, J, 1996) |
| "Hydralazine was then administered; the effects on regional resistance and blood flow were evaluated with a radionuclide-labeled microsphere technique." | 1.28 | Differential effects of intravenous hydralazine on myoendometrial and placental blood flow in hypertensive pregnant ewes. ( Barnard, JM; Henry, JB; Pedron, SL; Phernetton, TM; Rankin, JH; Reid, DL, 1992) |
| "Hydralazine failed to inhibit responses to any of the agonists tested in the fetal and maternal arteries." | 1.28 | Effects of vasodilators on isolated human uteroplacental arteries. ( Allen, J; Forman, A; Maigaard, S; Skajaa, K, 1991) |
| "Hydralazine to lower the diastolic blood pressure somewhat, when it was 110 mm Hg or higher, prevented intracranial hemorrhage." | 1.27 | The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. ( Cunningham, FG; Pritchard, JA; Pritchard, SA, 1984) |
| "1-4%, w/w) in three separate experiments: (1) a 2-week dose-response study; (2) a 2-month long-term feeding study; and (3) a pregnancy study." | 1.27 | Effect of the antihypertensive drug hydralazine on mineral metabolism in the rat. ( Keen, CL; Lönnerdal, B; Peters, JM, 1988) |
| "A case of severe preeclampsia in which hemolysis and rapid platelet consumption persisted after delivery, but in which the blood urea nitrogen and serum glutamic oxaloacetic acid transaminase levels returned to normal is presented." | 1.27 | Severe preeclampsia with persistent postpartum hemolysis and thrombocytopenia treated by plasmapheresis. ( Brenner, W; Schwartz, ML, 1985) |
| "Pregnancies complicated by severe preeclampsia in the second trimester are associated with a high incidence of perinatal morbidity and mortality." | 1.27 | Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. ( Abdella, TN; Anderson, GD; Brooks, TF; Sibai, BM; Spinnato, JA; Taslimi, M, 1985) |
| "Autonomic hyperreflexia is a serious peripartum complication associated with spinal cord lesions." | 1.27 | Management of autonomic hyperreflexia associated with a low thoracic spinal cord lesion. ( Gimovsky, ML; Ojeda, A; Ozaki, R; Zerne, S, 1985) |
| "Although the recognition and treatment of preeclampsia theoretically should eliminate eclampsia, it has not disappeared and remains a substantial threat to maternal and fetal well-being." | 1.26 | Eclampsia: treatment and referral. ( Anderson, GD; Dilts, PV; McCubbin, JH; Sibai, BM, 1982) |
| "Pregnancy-related hypertension is not thought to be an absolute contraindication to glucocorticoid therapy for the induction of pulmonary maturity." | 1.26 | Glucocorticoid therapy for the induction of pulmonary maturity in severely hypertensive gravid women. ( Nochimson, DJ; Petrie, RH, 1979) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 1.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 194 (61.39) | 18.7374 |
| 1990's | 44 (13.92) | 18.2507 |
| 2000's | 28 (8.86) | 29.6817 |
| 2010's | 35 (11.08) | 24.3611 |
| 2020's | 15 (4.75) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, HZ | 1 |
| Cheng, Y | 1 |
| Yu, D | 1 |
| Li, JB | 1 |
| Jiang, YF | 1 |
| Zhu, ZN | 1 |
| Muhammad, S | 1 |
| Usman, H | 1 |
| Dawha, YM | 1 |
| Yahya, A | 1 |
| Yekeen, A | 1 |
| Bako, B | 1 |
| Greene, NH | 1 |
| Pon, FF | 1 |
| Kilpatrick, SJ | 4 |
| Taguchi, R | 1 |
| Shigemi, D | 1 |
| Yasunaga, H | 1 |
| Wautlet, CK | 1 |
| Hoffman, MC | 1 |
| Shahzad Qamar, A | 1 |
| Zamir, A | 1 |
| Khalid, S | 1 |
| Ashraf, W | 1 |
| Imran, I | 1 |
| Hussain, I | 1 |
| Rehman, AU | 1 |
| Saeed, H | 1 |
| Majeed, A | 1 |
| Alqahtani, F | 1 |
| Rasool, MF | 1 |
| Kim, MK | 1 |
| Choe, KR | 1 |
| Jeong, DE | 1 |
| Lee, KN | 1 |
| Cho, I | 1 |
| Kim, HJ | 1 |
| Park, JY | 1 |
| S, D | 1 |
| Novri, DA | 1 |
| Hamidy, Y | 1 |
| Savira, M | 1 |
| Kausar, M | 1 |
| Husain, S | 1 |
| Hussain, R | 1 |
| Bhat, AD | 1 |
| Keasler, PM | 1 |
| Kolluru, L | 1 |
| Dombrowski, MM | 1 |
| Palanisamy, A | 1 |
| Singh, PM | 1 |
| Andrade, FO | 1 |
| Nguyen, NM | 1 |
| Warri, A | 2 |
| Hilakivi-Clarke, L | 2 |
| Antza, C | 1 |
| Dimou, C | 1 |
| Doundoulakis, I | 1 |
| Akrivos, E | 1 |
| Stabouli, S | 1 |
| Haidich, AB | 1 |
| Goulis, DG | 1 |
| Kotsis, V | 1 |
| Kantorowska, A | 1 |
| Heiselman, CJ | 1 |
| Halpern, TA | 1 |
| Akerman, MB | 1 |
| Elsayad, A | 1 |
| Muscat, JC | 1 |
| Sicuranza, GB | 1 |
| Vintzileos, AM | 1 |
| Heo, HJ | 1 |
| Chera-Aree, P | 1 |
| Tengtrakulcharoen, P | 1 |
| Leetheeragul, J | 1 |
| Sampaojarean, U | 1 |
| Surasereewong, S | 1 |
| Wataganara, T | 1 |
| Larkin, BP | 1 |
| Saad, S | 1 |
| Glastras, SJ | 1 |
| Nguyen, LT | 1 |
| Hou, M | 1 |
| Chen, H | 1 |
| Wang, R | 1 |
| Pollock, CA | 1 |
| Leible, S | 1 |
| Canals, A | 1 |
| Walton, R | 1 |
| Mitelman, G | 1 |
| Castiglione, A | 1 |
| Biron, M | 1 |
| Faundez, R | 1 |
| Sepulveda, W | 1 |
| Sharma, KJ | 2 |
| Amaral, LM | 1 |
| Wallace, K | 1 |
| Owens, M | 1 |
| LaMarca, B | 1 |
| Sharma, C | 1 |
| Soni, A | 1 |
| Gupta, A | 1 |
| Verma, A | 1 |
| Verma, S | 1 |
| Watson, K | 1 |
| Broscious, R | 1 |
| Devabhakthuni, S | 1 |
| Noel, ZR | 1 |
| Sridharan, K | 1 |
| Sequeira, RP | 1 |
| Maaløe, N | 1 |
| Andersen, CB | 1 |
| Housseine, N | 1 |
| Meguid, T | 1 |
| Bygbjerg, IC | 1 |
| van Roosmalen, J | 1 |
| Leavitt, K | 1 |
| Običan, S | 1 |
| Yankowitz, J | 1 |
| Habashi, JP | 1 |
| MacFarlane, EG | 1 |
| Bagirzadeh, R | 1 |
| Bowen, C | 1 |
| Huso, N | 1 |
| Chen, Y | 1 |
| Bedja, D | 1 |
| Creamer, TJ | 1 |
| Rykiel, G | 1 |
| Manning, M | 1 |
| Huso, D | 1 |
| Dietz, HC | 1 |
| Han, LW | 1 |
| Ryu, RJ | 1 |
| Cusumano, M | 1 |
| Easterling, TR | 2 |
| Phillips, BR | 1 |
| Risler, LJ | 1 |
| Shen, DD | 1 |
| Hebert, MF | 1 |
| Alexander, JM | 1 |
| Wilson, KL | 1 |
| Arulkumaran, N | 1 |
| Lightstone, L | 1 |
| Homam, H | 1 |
| Moukhah, S | 1 |
| Alizadeh, M | 1 |
| Gevaert, S | 1 |
| De Pauw, M | 1 |
| Tromp, F | 1 |
| Ascoop, AK | 1 |
| Roelens, K | 1 |
| De Backer, J | 1 |
| Firoz, T | 1 |
| Magee, LA | 3 |
| MacDonell, K | 1 |
| Payne, BA | 1 |
| Gordon, R | 1 |
| Vidler, M | 1 |
| von Dadelszen, P | 2 |
| Gangooly, S | 1 |
| Muttukrishna, S | 1 |
| Jauniaux, E | 1 |
| Vadhera, RB | 1 |
| Simon, M | 1 |
| Morris, R | 1 |
| Sunesara, I | 1 |
| Darby, M | 1 |
| Novotny, S | 1 |
| Kiprono, L | 1 |
| Bautista, L | 1 |
| Sawardecker, S | 1 |
| Bofill, J | 1 |
| Anderson, B | 1 |
| Martin, JN | 3 |
| Maille, N | 1 |
| Gokina, N | 2 |
| Mandalà, M | 3 |
| Colton, I | 1 |
| Osol, G | 3 |
| Garg, D | 1 |
| Rahaman, B | 1 |
| Stein, EG | 1 |
| Dickman, E | 1 |
| Olson-Chen, C | 1 |
| Seligman, NS | 1 |
| Abreo, A | 1 |
| Greene, N | 2 |
| Melsop, K | 1 |
| Peterson, N | 1 |
| Shields, LE | 1 |
| Main, EK | 1 |
| Rodriguez, M | 1 |
| Aghajanian, P | 1 |
| Bouker, KB | 1 |
| Zhang, X | 1 |
| Cook, KL | 1 |
| Jin, L | 1 |
| Zwart, A | 1 |
| Nguyen, N | 1 |
| Hu, R | 1 |
| Cruz, MI | 1 |
| de Assis, S | 1 |
| Wang, X | 1 |
| Xuan, J | 1 |
| Wang, Y | 1 |
| Wehrenberg, B | 1 |
| Clarke, R | 1 |
| Barton, JR | 1 |
| Sibai, BM | 5 |
| Kawasaki, S | 1 |
| Kako, K | 1 |
| Nagashima, Y | 1 |
| Kanou, A | 1 |
| Ishida, J | 1 |
| Fukamizu, A | 1 |
| Yancey, LM | 1 |
| Withers, E | 1 |
| Bakes, K | 1 |
| Abbott, J | 1 |
| Machaalani, R | 1 |
| Makris, A | 3 |
| Thornton, C | 2 |
| Hennessy, A | 3 |
| Thadani, U | 1 |
| Jacob, RG | 1 |
| McCoy, S | 1 |
| Baldwin, K | 1 |
| Barron, C | 2 |
| Ishii, M | 1 |
| Hattori, A | 1 |
| Numaguchi, Y | 1 |
| Ma, X | 1 |
| Nagasaka, T | 1 |
| Tsujimoto, M | 1 |
| Murohara, T | 1 |
| Kobayashi, H | 1 |
| Mizutani, S | 1 |
| Kawamura, M | 1 |
| Itoh, H | 1 |
| Yura, S | 1 |
| Mogami, H | 1 |
| Fujii, T | 1 |
| Kanayama, N | 1 |
| Konishi, I | 1 |
| Baggio, MR | 1 |
| Martins, WP | 1 |
| Calderon, AC | 1 |
| Berezowski, AT | 1 |
| Marcolin, AC | 1 |
| Duarte, G | 1 |
| Cavalli, RC | 1 |
| Archer, TL | 1 |
| Conrad, BE | 1 |
| Rezaei, Z | 1 |
| Sharbaf, FR | 1 |
| Pourmojieb, M | 1 |
| Youefzadeh-Fard, Y | 1 |
| Motevalian, M | 1 |
| Khazaeipour, Z | 1 |
| Esmaeili, S | 1 |
| Teran, E | 1 |
| Briones, F | 1 |
| Nicolalde, V | 1 |
| Vivero, S | 1 |
| Chedraui, P | 1 |
| Pérez-López, FR | 1 |
| Sangalli, JR | 1 |
| De Bem, TH | 1 |
| Perecin, F | 1 |
| Chiaratti, MR | 1 |
| Oliveira, Lde J | 1 |
| de Araújo, RR | 1 |
| Valim Pimentel, JR | 1 |
| Smith, LC | 1 |
| Meirelles, FV | 1 |
| Liu, QQ | 1 |
| Yu, YH | 1 |
| Gong, SP | 1 |
| Huang, LP | 1 |
| Choi, JH | 1 |
| Yoo, KH | 1 |
| Cheon, HW | 1 |
| Kim, KB | 1 |
| Hong, YS | 1 |
| Lee, JW | 1 |
| Kim, SK | 1 |
| Kim, CH | 1 |
| Sato, N | 1 |
| Tanaka, KA | 1 |
| Szlam, F | 1 |
| Tsuda, A | 1 |
| Arias, ME | 1 |
| Levy, JH | 1 |
| Adams, KM | 1 |
| Mandel, LS | 1 |
| Guthrie, KA | 1 |
| Atkinson, MW | 1 |
| Sameshima, H | 1 |
| Kawagoe, Y | 1 |
| Ikenoue, T | 1 |
| Sakamoto, H | 1 |
| ASSALI, NS | 6 |
| SUYEMOTO, R | 2 |
| COHEN, BM | 1 |
| KAPLAN, S | 1 |
| OIGHENSTEIN, S | 1 |
| KAPLAN, SA | 1 |
| McCALL, ML | 2 |
| RENZI, AA | 1 |
| GAUNT, R | 1 |
| GIAROLA, A | 1 |
| SHERMAN, RL | 2 |
| RIVA, HL | 2 |
| FINNERTY, FA | 1 |
| JORDAN, WK | 1 |
| DRAPS, H | 1 |
| CHAPMAN, ER | 1 |
| STROZIER, WE | 1 |
| MAGEE, RA | 1 |
| DRAPS, MH | 1 |
| PICKHARDT, WL | 1 |
| HOLZWORTH, RH | 1 |
| QUINZANI, F | 1 |
| TALAS, M | 1 |
| HECZKO, P | 1 |
| VASKOVA, M | 1 |
| FARRIS, C | 1 |
| KRUPP, PJ | 1 |
| BRYANT, RD | 1 |
| SUNDFOR, H | 1 |
| JOHNSON, GT | 1 |
| THOMPSON, RB | 1 |
| LINDHOLM, T | 1 |
| GRODY, MH | 1 |
| SATTENSPIEL, E | 1 |
| SMITH, GC | 1 |
| BECK, L | 1 |
| MOLUMPHY, PE | 1 |
| GARCIA, R | 1 |
| HOPFGARTNER, A | 1 |
| TACCHI, D | 1 |
| SPIELMANN, W | 1 |
| KAHN, K | 1 |
| KAMAL, I | 1 |
| DAVIS, CD | 1 |
| GOLDBERG, LC | 1 |
| NEWTON, M | 1 |
| KROGSGAARD, AR | 1 |
| ALEXANDER, JA | 3 |
| ROGERS, SF | 3 |
| JACOBS, WM | 2 |
| WILLS, SH | 2 |
| URANGAIMAZ, FA | 2 |
| TONNELIER, E | 1 |
| KLAUER, D | 1 |
| CHEKERDEMIAN, M | 1 |
| SARLES, HE | 1 |
| HERRING, ME | 1 |
| WATSON, TF | 1 |
| GREGORY, RL | 1 |
| REMMERS, AR | 1 |
| BELONOSCHKIN, B | 1 |
| MANCINI, RT | 1 |
| GAUTIERI, RF | 3 |
| MACLAVERTY, MP | 1 |
| PAVLIC, RS | 1 |
| SMITH, CJ | 1 |
| ASHE, JR | 1 |
| THOMAS, WL | 1 |
| Thigpen, BD | 1 |
| Rose, CH | 1 |
| Cushman, J | 1 |
| Moore, A | 1 |
| May, WL | 1 |
| Cham, C | 1 |
| Waterman, EJ | 1 |
| Ohlsson, A | 1 |
| Winston, AW | 1 |
| Norman, D | 1 |
| Houlihan, DD | 1 |
| Dennedy, MC | 1 |
| Ravikumar, N | 1 |
| Morrison, JJ | 1 |
| Heazell, AE | 1 |
| Mahomoud, S | 1 |
| Pirie, AM | 1 |
| Xu, B | 1 |
| Ogle, R | 1 |
| Horvath, JS | 3 |
| Thornton, CE | 1 |
| Ogle, RF | 1 |
| Henderson-Smart, DJ | 1 |
| Gillin, AG | 1 |
| Child, A | 2 |
| Olatunji, AO | 1 |
| Sule-Odu, AO | 1 |
| Volach, V | 1 |
| Elami, A | 1 |
| Gilon, D | 1 |
| Pollak, A | 1 |
| Ginosar, Y | 1 |
| Ezra, Y | 1 |
| Omu, AE | 2 |
| Al-Harmi, J | 1 |
| Vedi, HL | 1 |
| Mlechkova, L | 1 |
| Sayed, AF | 1 |
| Al-Ragum, NS | 1 |
| Kreisberg, RA | 1 |
| Morgan, J | 1 |
| Carmichael, E | 1 |
| Pittman, J | 1 |
| Chesley, LC | 1 |
| Richter, R | 1 |
| Sandström, B | 6 |
| Hayashi, RH | 1 |
| Liedholm, H | 2 |
| Melander, A | 2 |
| Lubbe, WF | 1 |
| Fujita, S | 1 |
| Yamauchi, C | 1 |
| Prichard, BN | 1 |
| Liu, TL | 1 |
| Holzgreve, H | 1 |
| Knuppel, RA | 1 |
| Montenegro, R | 1 |
| Tullio, D | 1 |
| Redman, CW | 4 |
| Ram, CV | 1 |
| Petty, R | 1 |
| Medley, DR | 1 |
| Skret, A | 2 |
| Kuźniar, J | 2 |
| Piela, A | 2 |
| Zaczek, T | 2 |
| Szmigiel, Z | 2 |
| Hankins, GD | 1 |
| Wendel, GD | 1 |
| Cunningham, FG | 4 |
| Leveno, KJ | 1 |
| Lindeberg, S | 3 |
| Lundborg, P | 2 |
| Regårdh, CG | 2 |
| Lunell, NO | 2 |
| Lewander, R | 1 |
| Nylund, L | 2 |
| Sarby, B | 1 |
| Thornström, S | 1 |
| Walker, JJ | 2 |
| Greer, I | 1 |
| Calder, AA | 1 |
| Hod, M | 2 |
| Friedman, S | 3 |
| Theodor, E | 1 |
| Ovadia, J | 4 |
| Rocchi, G | 1 |
| Pritchard, JA | 5 |
| Pritchard, SA | 2 |
| Liebowitz, HA | 1 |
| Hall, PE | 1 |
| Weiner, CP | 2 |
| Gelfan, R | 1 |
| Socol, ML | 1 |
| Montminy, M | 1 |
| Teres, D | 1 |
| Drayer, JI | 1 |
| Weber, MA | 1 |
| Berkowitz, RL | 2 |
| McCubbin, JH | 1 |
| Anderson, GD | 3 |
| Dilts, PV | 1 |
| Karasawa, T | 1 |
| Hayano, Y | 1 |
| Imai, N | 1 |
| Vink, GJ | 2 |
| Moodley, J | 5 |
| Garden, A | 1 |
| Davey, DA | 2 |
| Dommisse, J | 2 |
| Wåhlin-Boll, E | 1 |
| Hanson, A | 1 |
| Ingemarsson, I | 1 |
| Davey, M | 1 |
| Soutter, P | 1 |
| Welt, SI | 1 |
| Dorminy, JH | 1 |
| Jelovsek, FR | 1 |
| Crenshaw, MC | 1 |
| Gall, SA | 1 |
| Reeves, JT | 1 |
| Bott-Kanner, G | 3 |
| Schweitzer, A | 2 |
| Reisner, SH | 1 |
| Joel-Cohen, SJ | 1 |
| Rosenfeld, JB | 2 |
| Philpott, RH | 2 |
| Widerlöv, E | 1 |
| Karlman, I | 1 |
| Storsäter, J | 1 |
| Lamming, GD | 1 |
| Broughton Pipkin, F | 1 |
| Symonds, EM | 1 |
| Iams, JD | 1 |
| Semchyshyn, S | 1 |
| O'Shaughnessy, R | 1 |
| Moynihan, V | 1 |
| Zuspan, FP | 1 |
| Rubin, LJ | 1 |
| Peter, RH | 1 |
| Sato, K | 1 |
| Kojima, M | 1 |
| Dohi, Y | 1 |
| Yeowell, HN | 1 |
| Marshall, MK | 1 |
| Walker, LC | 1 |
| Ha, V | 1 |
| Pinnell, SR | 1 |
| Leitch, IM | 1 |
| Read, MA | 1 |
| Boura, AL | 1 |
| Walters, WA | 2 |
| Gudmundsson, S | 1 |
| Gennser, G | 1 |
| Marsal, K | 1 |
| Duley, L | 2 |
| Rossouw, HJ | 1 |
| Howarth, G | 1 |
| Odendaal, HJ | 1 |
| Cervar, M | 1 |
| Kainer, F | 1 |
| Desoye, G | 1 |
| Levin, AC | 1 |
| Doering, PL | 1 |
| Hatton, RC | 1 |
| Hsueh, WA | 1 |
| Belfort, MA | 1 |
| Saade, GR | 1 |
| Suresh, M | 1 |
| Johnson, D | 1 |
| Vedernikov, YP | 1 |
| Paran, E | 2 |
| Holzberg, G | 1 |
| Mazor, M | 1 |
| Zmora, E | 2 |
| Insler, V | 1 |
| Bowlby, H | 1 |
| Paterson-Brown, S | 1 |
| Robson, SC | 1 |
| Redfern, N | 1 |
| Walkinshaw, SA | 1 |
| de Swiet, M | 1 |
| Gant, NF | 3 |
| Pryde, PG | 1 |
| Abel, EL | 1 |
| Hannigan, J | 1 |
| Evans, MI | 1 |
| Cotton, DB | 4 |
| Hjertberg, R | 2 |
| Faxelius, G | 2 |
| Belfrage, P | 1 |
| Pue, AF | 1 |
| Walss Rodriguez, RJ | 2 |
| Flores Padilla, LM | 1 |
| Lagercrantz, H | 1 |
| López-Jaramillo, P | 1 |
| Narváez, M | 1 |
| Calle, A | 1 |
| Rivera, J | 1 |
| Jácome, P | 1 |
| Ruano, C | 1 |
| Nava, E | 1 |
| Jegasothy, R | 1 |
| Paranthaman, S | 1 |
| Nasu, K | 1 |
| Yoshimatsu, J | 1 |
| Anai, T | 1 |
| Miyakawa, I | 1 |
| Makhseed, M | 1 |
| al-Qattan, F | 1 |
| Suzuki, H | 1 |
| Kwawukume, EY | 1 |
| Ghosh, TS | 1 |
| Curtis, KS | 1 |
| Cunningham, JT | 1 |
| Heesch, CM | 1 |
| Martínez-Abundis, E | 1 |
| González-Ortiz, M | 1 |
| Cortés-Llamas, V | 1 |
| Salazar-Páramo, M | 1 |
| Magee, KP | 1 |
| Bawdon, RE | 1 |
| Edwards, N | 1 |
| Blyton, CM | 1 |
| Kesby, GJ | 1 |
| Wilcox, I | 1 |
| Sullivan, CE | 1 |
| El-Dahr, SS | 1 |
| Harrison-Bernard, LM | 1 |
| Dipp, S | 1 |
| Yosipiv, IV | 1 |
| Meleg-Smith, S | 1 |
| Bull, SB | 1 |
| Koren, G | 1 |
| Logan, A | 1 |
| Hassan, K | 1 |
| Weissmam, I | 1 |
| Osman, S | 1 |
| Gery, R | 1 |
| Oettinger, M | 1 |
| Shasha, SM | 1 |
| Kristal, B | 1 |
| Hussein, M | 1 |
| Mooij, JM | 1 |
| Roujouleh, H | 1 |
| Anato, V | 1 |
| Garmendia, JV | 1 |
| Bianco, NE | 1 |
| De Sanctis, JB | 1 |
| Aali, BS | 1 |
| Nejad, SS | 1 |
| Monnier, JC | 1 |
| Honore, P | 1 |
| Lanciaux, B | 1 |
| Boulogne, M | 1 |
| Madden, JD | 1 |
| Siiteri, PK | 1 |
| MacDonald, PC | 1 |
| Romankiewicz, JA | 1 |
| Lammintausta, R | 1 |
| Curet, LB | 1 |
| Olson, RW | 1 |
| Becker, CE | 1 |
| Benowitz, NL | 1 |
| Arias, F | 1 |
| Zamora, J | 1 |
| Henrich, WL | 1 |
| Cronin, R | 1 |
| Miller, PD | 1 |
| Anderson, RJ | 1 |
| Nochimson, DJ | 1 |
| Petrie, RH | 1 |
| Worley, RJ | 1 |
| Whalley, PJ | 1 |
| Schoenfeld, A | 1 |
| Joel-Cohen, J | 1 |
| Adelman, RD | 1 |
| Merten, D | 1 |
| Vogel, J | 1 |
| Goetzman, BW | 1 |
| Wennberg, RP | 1 |
| Armon, PJ | 1 |
| Hibbard, BM | 1 |
| Rosen, M | 1 |
| Kelly, JV | 1 |
| Ring, G | 1 |
| Krames, E | 1 |
| Shnider, SM | 2 |
| Wallis, KL | 1 |
| Levinson, G | 1 |
| Brinkman, CR | 4 |
| Pascual, AV | 1 |
| Woods, JR | 1 |
| Freis, ED | 1 |
| Ragan, D | 1 |
| Shvarts, R | 1 |
| Rettske, U | 1 |
| Duggan, PM | 1 |
| McCowan, LM | 1 |
| Stewart, AW | 1 |
| Pedron, SL | 1 |
| Reid, DL | 1 |
| Barnard, JM | 1 |
| Henry, JB | 1 |
| Phernetton, TM | 1 |
| Rankin, JH | 1 |
| Baumann, P | 1 |
| Künzel, W | 1 |
| Vertommen, JD | 1 |
| Hughes, SC | 1 |
| Rosen, MA | 1 |
| Espinoza, MI | 1 |
| Messer, CP | 1 |
| Johnson, JL | 1 |
| Parer, JT | 1 |
| Mooij, PN | 1 |
| Nijhuis, JG | 1 |
| Jongsma, HW | 1 |
| Menssen, JJ | 1 |
| Catanzarite, V | 1 |
| Quirk, JG | 1 |
| Aisenbrey, G | 1 |
| Fairlie, FM | 1 |
| Villarreal Ordaz, F | 1 |
| Fenakel, K | 1 |
| Fenakel, G | 1 |
| Appelman, Z | 1 |
| Lurie, S | 1 |
| Katz, Z | 1 |
| Shoham, Z | 2 |
| Phippard, AF | 1 |
| Fischer, WE | 1 |
| Child, AG | 1 |
| Korda, AR | 1 |
| Henderson-Smart, D | 2 |
| Duggin, GG | 2 |
| Tiller, DJ | 2 |
| Allen, J | 1 |
| Skajaa, K | 1 |
| Maigaard, S | 1 |
| Forman, A | 1 |
| Kirshon, B | 2 |
| Wasserstrum, N | 2 |
| Flowers, D | 1 |
| Clark, JF | 1 |
| Westney, LS | 1 |
| Harper, A | 1 |
| Murnaghan, GA | 1 |
| Plouin, PF | 1 |
| Breart, G | 1 |
| Llado, J | 1 |
| Dalle, M | 1 |
| Keller, ME | 1 |
| Goujon, H | 1 |
| Berchel, C | 1 |
| Derham, RJ | 2 |
| Robinson, J | 1 |
| Hawkins, DF | 1 |
| De Vries, LS | 1 |
| Aber, VR | 1 |
| Elder, MG | 1 |
| Yemini, M | 1 |
| Dgani, R | 1 |
| Lancet, M | 1 |
| Mogilner, BM | 1 |
| Nissim, F | 1 |
| Bar-Khayim, Y | 1 |
| Rossavik, IK | 1 |
| Willis, RS | 1 |
| Moise, KJ | 1 |
| Griffis, KR | 1 |
| Palmer, SM | 1 |
| Martin, RW | 1 |
| Morrison, JC | 2 |
| Belfort, M | 1 |
| Uys, P | 1 |
| Chervenak, FA | 1 |
| Gallery, ED | 2 |
| Naden, RP | 1 |
| Durando, C | 1 |
| Leidi, L | 1 |
| Margaria, E | 1 |
| Medaglia, M | 1 |
| Gessa, M | 1 |
| Maina, G | 1 |
| Rubin, PC | 1 |
| Widerhorn, J | 1 |
| Rubin, JN | 1 |
| Frishman, WH | 1 |
| Elkayam, U | 1 |
| Benedetti, TJ | 1 |
| Schmucker, BC | 1 |
| Carlson, KL | 1 |
| Lodeiro, JG | 1 |
| Feinstein, SJ | 1 |
| Lodeiro, SB | 1 |
| Balkovetz, DF | 1 |
| Tiruppathi, C | 1 |
| Leibach, FH | 1 |
| Mahesh, VB | 1 |
| Ganapathy, V | 1 |
| Sullivan, JM | 1 |
| Holm, B | 1 |
| Mabie, WC | 1 |
| Gonzalez, AR | 1 |
| Amon, E | 1 |
| Brengman, SL | 1 |
| Burns, MK | 1 |
| Nelson, SH | 1 |
| Suresh, MS | 1 |
| Peters, JM | 1 |
| Lönnerdal, B | 1 |
| Keen, CL | 1 |
| Smeda, JS | 1 |
| Lee, RM | 1 |
| Forrest, JB | 1 |
| Herrig, J | 1 |
| Wang, J | 1 |
| Wang, L | 1 |
| Farley, D | 1 |
| Van Orden, D | 1 |
| Chestnut, D | 1 |
| Hoffmann, P | 1 |
| Bartels, T | 1 |
| Heinemann, S | 1 |
| Beitz, J | 1 |
| Taube, C | 1 |
| Ashe, RG | 1 |
| Richards, AM | 1 |
| Vasant, RV | 1 |
| Reti, LL | 1 |
| Ross, A | 1 |
| Kloss, M | 1 |
| Paull, J | 1 |
| Markman, L | 1 |
| Spinnato, JA | 2 |
| Barnea, ER | 1 |
| Fakih, H | 1 |
| Oelsner, G | 1 |
| Walner, S | 1 |
| DeCherney, AH | 1 |
| Naftolin, F | 1 |
| Neri, A | 1 |
| Nitke, S | 1 |
| Lachman, E | 1 |
| Rading, A | 1 |
| Kehrbein, C | 1 |
| Benndorf, S | 1 |
| Steinig, G | 1 |
| Nahrendorf, W | 1 |
| Weidler, B | 1 |
| Suonio, S | 1 |
| Saarikoski, S | 1 |
| Tahvanainen, K | 1 |
| Pääkkönen, A | 1 |
| Olkkonen, H | 1 |
| Rosenfeld, J | 1 |
| Boner, G | 1 |
| Nissenkorn, A | 1 |
| Merlob, P | 1 |
| Reisner, S | 1 |
| Chopra, A | 1 |
| Chib, P | 1 |
| Singh, RP | 1 |
| Prabhakaran, SN | 1 |
| Goodlin, RC | 1 |
| Lipshitz, J | 1 |
| Ahokas, RA | 1 |
| Reynolds, SL | 1 |
| Jouppila, P | 1 |
| Kirkinen, P | 1 |
| Koivula, A | 1 |
| Ylikorkala, O | 1 |
| Högstedt, S | 1 |
| Axelsson, O | 1 |
| Lindmark, G | 1 |
| Rane, A | 1 |
| Lindberg, BS | 1 |
| Ross, MR | 1 |
| Gyory, AZ | 1 |
| Franke, G | 1 |
| Pietsch, P | 1 |
| Schneider, T | 1 |
| Siegmund, W | 1 |
| Grabow, D | 1 |
| Schütz, H | 1 |
| Schwartz, ML | 1 |
| Brenner, W | 1 |
| Redgrave, JE | 1 |
| Swartz, SL | 1 |
| Whitworth, NS | 1 |
| Bates, GW | 1 |
| McKay, ML | 1 |
| Gookin, KS | 1 |
| Wiser, WL | 1 |
| Friesen, HG | 1 |
| Taslimi, M | 1 |
| Abdella, TN | 1 |
| Brooks, TF | 1 |
| Korda, A | 1 |
| Phippard, A | 1 |
| Hall, BM | 1 |
| Gonik, B | 1 |
| Dorman, KF | 1 |
| Gimovsky, ML | 1 |
| Ojeda, A | 1 |
| Ozaki, R | 1 |
| Zerne, S | 1 |
| Kincaid-Smith, P | 1 |
| Abella, R | 1 |
| Blondeel, NJ | 1 |
| Roguska, J | 1 |
| Walker, C | 1 |
| Simon, NM | 1 |
| Del Greco, F | 1 |
| Ward, CO | 2 |
| Ladner, C | 1 |
| Weston, P | 1 |
| Martin, JD | 1 |
| Leroux-Robert, C | 1 |
| Beaufils, M | 1 |
| Richet, G | 1 |
| Tischler, E | 1 |
| Joyce, DN | 1 |
| Kenyon, VG | 1 |
| Fernandes, M | 1 |
| Kim, KE | 1 |
| Moyer, JH | 1 |
| Wilber, JA | 1 |
| Haller, J | 1 |
| Eklöf-Slangus, S | 1 |
| Baskett, TF | 1 |
| Bradford, CR | 1 |
| Tucker, RM | 1 |
| Hunt, JC | 1 |
| Vaidya, RA | 1 |
| Vaidya, AB | 1 |
| Van Woert, MH | 1 |
| Kase, NG | 1 |
| Harbert, GM | 1 |
| Cornell, GW | 1 |
| Thornton, WN | 1 |
| Graf, H | 1 |
| Nohira, T | 1 |
| Hohe, PT | 1 |
| Cochrane, CR | 1 |
| Gmelich, JT | 1 |
| Austin, JA | 1 |
| Ragni, N | 1 |
| Cadenelli, GP | 1 |
| Stone, SR | 1 |
| Jorring, K | 1 |
| Ladner, CN | 1 |
| Weston, PV | 1 |
| Evans, DA | 1 |
| Heinrich, F | 1 |
| Schultis, K | 1 |
| Flowers, CE | 1 |
| Harley, JM | 1 |
| Cretti, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The PartoMa Project for Saving Lives at Birth - An Intervention Based Study to Strengthen the Quality of Monitoring, Action and Triage During Labour at an East African Referral Hospital[NCT02318420] | 3,087 participants (Actual) | Interventional | 2014-10-01 | Completed | |||
| Use of Sildenafil Citrate in Management of Mild Pre-eclampsia: A Randomized Controlled Trial[NCT03262961] | Phase 2/Phase 3 | 80 participants (Anticipated) | Interventional | 2016-09-15 | Recruiting | ||
| A Comparison of Fetal Hemodynamic Measurements Between Pregnant Women Taking Anti-hypertensive Medication and Controls[NCT00759278] | 0 participants (Actual) | Observational | 2008-08-31 | Withdrawn (stopped due to No participants) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
46 reviews available for hydralazine and Pregnancy
| Article | Year |
|---|---|
Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypertension, Pr | 2022 |
Hypertensive Crisis in Pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; Nifedipine; Pregnancy | 2022 |
A review on the clinical pharmacokinetics of hydralazine.
Topics: Drug-Related Side Effects and Adverse Reactions; Female; Heart Failure; Humans; Hydralazine; Hyperte | 2022 |
Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hydralazine; Hypertension; Infant | 2023 |
The flipside of hydralazine in pregnancy: A systematic review and meta-analysis.
Topics: Antihypertensive Agents; Birth Weight; Female; Heart Rate; Humans; Hydralazine; Hypertension; Hypert | 2020 |
Postpartum Hypertension: Etiology, Diagnosis, and Management.
Topics: Antihypertensive Agents; Blood Pressure; Disease Management; Female; Humans; Hydralazine; Hypertensi | 2017 |
Pathophysiology and Current Clinical Management of Preeclampsia.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delivery, Obstetric; Endothelium, | 2017 |
Focused Update on Pharmacologic Management of Hypertensive Emergencies.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Emergencies; Enalapri | 2018 |
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hy | 2018 |
Treatment and Prevention of Hypertensive Disorders During Pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Chronic Dis | 2019 |
Hypertensive emergencies of pregnancy.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; | 2013 |
Severe pre-eclampsia and hypertensive crises.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Dia | 2013 |
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy- | 2014 |
Hypertensive emergencies in pregnancy.
Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hyperten | 2014 |
Hypertensive Emergencies in Pregnancy.
Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; E | 2016 |
Pharmacotherapeutic options for the treatment of preeclampsia.
Topics: Female; Humans; Hydralazine; Magnesium Sulfate; Nicardipine; Nifedipine; Nitroprusside; Pre-Eclampsi | 2009 |
[Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; | 2012 |
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
Topics: Antihypertensive Agents; Blood Pressure; Bradycardia; Female; Heart Rate, Fetal; Humans; Hydralazine | 2003 |
Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Aortic Diseases; Aortic Dissection; Blo | 2006 |
The control of hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Antihypertensive Agents; Diazoxide; Diuretics; Eclampsi | 1981 |
Management of the pregnant patient with chronic hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Humans; Hydralaz | 1983 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clon | 1984 |
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp | 1984 |
Preeclampsia--eclampsia: an overview.
Topics: Blood Pressure; Eclampsia; Electroencephalography; Female; Hospitalization; Humans; Hydralazine; Inf | 1983 |
[Arterial hypertension in pregnancy. Concise review].
Topics: Cesarean Section; Diet, Sodium-Restricted; Female; Humans; Hydralazine; Hypertension; Labor, Induced | 1983 |
The management of hypertension in pregnancy.
Topics: Cerebrovascular Circulation; Clinical Trials as Topic; Diazoxide; Diuretics; Female; Humans; Hydrala | 1984 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1984 |
Anti-hypertensive drugs in the pregnant patient.
Topics: Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Diuretics; Female; Fetus; Furosemide | 1980 |
Management of preeclampsia and eclampsia.
Topics: Anticonvulsants; Antihypertensive Agents; Delivery, Obstetric; Diuretics; Eclampsia; Female; Humans; | 1980 |
Treatment of hypertension in pregnancy.
Topics: Diazoxide; Diuretics; Female; Humans; Hydralazine; Hypertension; Methyldopa; Placenta; Pre-Eclampsia | 1980 |
Use of nifedipine in the hypertensive diseases of pregnancy.
Topics: Female; Humans; Hydralazine; Hypertension; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complicat | 1994 |
Management of eclampsia.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Eclampsia; Female; Fetal Diseases; Fetus; Humans; H | 1994 |
[Pregnancy induced hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bed Rest; Contraindications; Fema | 1997 |
The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Cohort Studies; Databases as Topic; Diabetes, Gestational; Femal | 2001 |
The use of antihypertensive drugs in hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Diuretic | 1977 |
Pharmacology and clinical use of drugs in hypertensive emergencies.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Aorta; Brain Diseases; Cerebral Hemorrhage; Diazox | 1977 |
How to manage hypertensive emergencies and urgencies.
Topics: Adult; Antihypertensive Agents; Aortic Aneurysm; Brain Diseases; Cerebrovascular Disorders; Diazoxid | 1976 |
Intracranial pressure and fetal heart rate in a hydrocephalic fetus during labor.
Topics: Adult; Drainage; Female; Heart Rate, Fetal; Humans; Hydralazine; Hydrocephalus; Intracranial Pressur | 1992 |
Severe preeclampsia: is vasodilation therapy with hydralazine dangerous for the preterm fetus?
Topics: Female; Fetus; Humans; Hydralazine; Hypotension; Pre-Eclampsia; Pregnancy | 1990 |
Hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Animals; Chronic Disease; Clonidine; Diuretics; Female; Humans; Hydrala | 1985 |
Hypertension in pregnant women.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Delivery, Obstetric; Diazoxide; Emergencies; F | 1985 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; H | 1985 |
Treatment of hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Eclampsia; Female; Human | 1986 |
Cardiovascular drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Agents; Digoxin; Female; Humans; | 1987 |
Hypertensive emergencies.
Topics: Acute Kidney Injury; Adrenal Gland Neoplasms; Antihypertensive Agents; Aortic Aneurysm; Blood Volume | 1974 |
Recent advances in the medical and surgical treatment of hypertension.
Topics: Adrenocortical Hyperfunction; Antihypertensive Agents; Diet, Sodium-Restricted; Diuretics; Ethacryni | 1968 |
37 trials available for hydralazine and Pregnancy
| Article | Year |
|---|---|
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Infant; Infant, | 2022 |
Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Labetalol; Nifedipine; Pre-Eclampsia; Pregnanc | 2022 |
Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial.
Topics: Acute Disease; Adolescent; Adult; Apgar Score; Double-Blind Method; Emergencies; Female; Humans; Hyd | 2017 |
Impedance cardiography assessed treatment of acute severe pregnancy hypertension: a randomized trial.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cardiography, Impedance; Female; Hum | 2016 |
Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
Topics: Acute Disease; Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; | 2011 |
Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; H | 2011 |
Treatment of nuclear-donor cells or cloned zygotes with chromatin-modifying agents increases histone acetylation but does not improve full-term development of cloned cattle.
Topics: Acetylation; Animals; Azacitidine; Cattle; Cell Nucleus; Cells, Cultured; Chromatin Assembly and Dis | 2012 |
A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.
Topics: Adult; Antihypertensive Agents; Cardiotocography; Cesarean Section; Diazoxide; Female; Humans; Hydra | 2007 |
The management of hypertension in pregnancy.
Topics: Cerebrovascular Circulation; Clinical Trials as Topic; Diazoxide; Diuretics; Female; Humans; Hydrala | 1984 |
Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
Topics: Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pregnanc | 1983 |
Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
Topics: Adult; Blood Pressure; Dihydralazine; Eclampsia; Ethanolamines; Female; Fetus; Humans; Hydralazine; | 1982 |
The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies.
Topics: Adult; Antihypertensive Agents; Birth Weight; Blood Pressure; Body Weight; Female; Humans; Hydralazi | 1981 |
Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
Topics: Adult; Blood Pressure; Creatinine; Ethanolamines; Female; Fetus; Humans; Hydralazine; Hypertension; | 1980 |
Effects of hydralazine on placental and renal circulation in pre-eclampsia.
Topics: Adult; Birth Weight; Blood Circulation; Blood Flow Velocity; Blood Pressure; Drug Evaluation; Female | 1995 |
Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial.
Topics: Adolescent; Adult; Blood Pressure; Double-Blind Method; Female; Humans; Hydralazine; Ketanserin; Pre | 1995 |
Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female | 1995 |
Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants.
Topics: Adult; Female; Humans; Hydralazine; Infant, Low Birth Weight; Infant, Newborn; Labetalol; Pre-Eclamp | 1993 |
[Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents].
Topics: Administration, Sublingual; Antihypertensive Agents; Apgar Score; Drug Evaluation; Eclampsia; Female | 1993 |
Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice.
Topics: Administration, Sublingual; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hydra | 1996 |
Effect of antihypertensive therapy in preeclampsia on levels of serum interleukin-4.
Topics: Adult; Antihypertensive Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydralazine; Infu | 1996 |
Oral nifedipine therapy in the management of severe preeclampsia.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Infusions, Intrav | 1995 |
Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia.
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Nifedipine; | 2002 |
The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy.
Topics: Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Dihydralazine; Electrolytes; Female; H | 1978 |
Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.
Topics: Arteries; Blood Flow Velocity; Double-Blind Method; Female; Humans; Hydralazine; Hypertension; Nifed | 1992 |
[Management of severe pre-eclampsia in the puerperium. Comparative study of sublingual nifedipine and hydralazine].
Topics: Administration, Sublingual; Adolescent; Adult; Antihypertensive Agents; Female; Humans; Hydralazine; | 1991 |
Nifedipine in the treatment of severe preeclampsia.
Topics: Adult; Blood Pressure; Female; Humans; Hydralazine; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy | 1991 |
Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension.
Topics: Adult; Birth Weight; Blood Pressure; Clonidine; Double-Blind Method; Drug Administration Schedule; D | 1991 |
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Heart Rate, Fetal; Hemodynamics; Hum | 1991 |
A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension.
Topics: Adult; Birth Weight; Cesarean Section; Dihydralazine; Double-Blind Method; Drug Therapy, Combination | 1990 |
Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension.
Topics: Blood Pressure; Fees, Pharmaceutical; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; | 1989 |
Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy.
Topics: Adult; Cardiac Output; Catheterization, Swan-Ganz; Dihydralazine; Female; Fluid Therapy; Hemodynamic | 1989 |
A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; H | 1987 |
Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
Topics: Blood Pressure; Clinical Trials as Topic; Dihydralazine; Female; Heart Rate; Heart Rate, Fetal; Huma | 1987 |
Lumbar epidural analgesia in hypertensive patients during labour.
Topics: Anesthesia, Epidural; Anesthesia, Obstetrical; Blood Pressure; Delivery, Obstetric; Female; Humans; | 1986 |
Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pindolo | 1986 |
A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy.
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fetus; Gestational Age; Humans; | 1985 |
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Humans; Hydralazine; Hypertension; Infant, Ne | 1985 |
234 other studies available for hydralazine and Pregnancy
| Article | Year |
|---|---|
Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Ethnicity; Female; Humans; Hydralazine; Hypertension; Labet | 2022 |
Trends in antihypertensive prescription for pregnant women with hypertension and their peripartum outcomes before and after label and guideline revisions in Japan.
Topics: Antihypertensive Agents; Cesarean Section; Drug Prescriptions; Female; Humans; Hydralazine; Hyperten | 2022 |
Use of continuous infusion of nicardipine to control persistent postpartum hypertension: A retrospective study.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Labetalol; Nicar | 2022 |
Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypotension; Lab | 2023 |
Reversal of increased mammary tumorigenesis by valproic acid and hydralazine in offspring of dams fed high fat diet during pregnancy.
Topics: Animals; Cell Transformation, Neoplastic; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Diet, | 2019 |
Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Topics: Administration, Intravenous; Administration, Oral; Adult; After-Hours Care; Antihypertensive Agents; | 2020 |
Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
Topics: Administration, Intravenous; Adult; Antihypertensive Agents; Apgar Score; Asian People; Blood Pressu | 2020 |
Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet.
Topics: Albuminuria; Animals; Biomarkers; Body Weight; Collagen; Diet, High-Fat; DNA Methylation; Female; Fi | 2021 |
First-trimester miscarriage rate decreases with hydralazine therapy in pregnancies with early uterine vascular insufficiency: a cohort study.
Topics: Abortion, Spontaneous; Cohort Studies; Female; Humans; Hydralazine; Pregnancy; Pregnancy Trimester, | 2022 |
Effect of locally tailored clinical guidelines on intrapartum management of severe hypertensive disorders at Zanzibar's tertiary hospital (the PartoMa study).
Topics: Anticonvulsants; Antihypertensive Agents; Apgar Score; Delivery, Obstetric; Female; Humans; Hydralaz | 2019 |
Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Aortic Dissection; Disease Models, Animal; Female; Hydr | 2019 |
Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.
Topics: Acetylation; Adult; Antihypertensive Agents; Area Under Curve; Arylamine N-Acetyltransferase; Female | 2019 |
Asymptomatic torsion of a gravid uterus.
Topics: Adult; Antihypertensive Agents; Asymptomatic Diseases; Cesarean Section; Female; Humans; Hydralazine | 2013 |
Treatment of pre-existing cardiomyopathy during pregnancy.
Topics: Adult; Antihypertensive Agents; Cardiomyopathy, Dilated; Female; Follow-Up Studies; Heart Failure; H | 2014 |
In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.
Topics: Activins; Angiogenic Proteins; Antigens, CD; Antihypertensive Agents; Chorionic Gonadotropin; Chorio | 2014 |
Mechanism of hydralazine-induced relaxation in resistance arteries during pregnancy: Hydralazine induces vasodilation via a prostacyclin pathway.
Topics: Animals; Antihypertensive Agents; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endot | 2016 |
Late Postpartum Eclampsia with Postpartum Angiopathy: An Uncommon Diagnosis in the Emergency Department.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Drug Therapy, Combination; Eclampsia; Emergency Ser | 2015 |
Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Topics: Adult; Antihypertensive Agents; California; Female; Humans; Hydralazine; Hypertension, Pregnancy-Ind | 2016 |
Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension, Pregnancy | 2016 |
Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenovirus E1A Proteins; Animals; Antineoplastic Combined Chemothe | 2017 |
Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Labetalol; Pre-E | 2017 |
Hydralazine is involved in tele-methylhistamine metabolism by inhibiting monoamine oxidase B in pregnancy-associated hypertensive mice.
Topics: Amines; Animals; Antihypertensive Agents; Biocatalysis; Chromatography, High Pressure Liquid; Female | 2017 |
Postpartum preeclampsia: emergency department presentation and management.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Antihypertensive Agents; Benzodiazepines; E | 2011 |
Vascular endothelial growth factor receptor 1 (Flt1) and apoptosis in the preeclamptic placenta and effects of in vivo anti-hypertensive exposure.
Topics: Adult; Antihypertensive Agents; Apoptosis; Case-Control Studies; Clonidine; Female; Fetal Growth Ret | 2008 |
Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
Topics: Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Interactions; D | 2008 |
Inhibition of nitric oxide synthases abrogates pregnancy-induced uterine vascular expansive remodeling.
Topics: Animals; Arteries; Blood Pressure; Enzyme Inhibitors; Female; Fertility; Hydralazine; Hypertension, | 2009 |
The effect of recombinant aminopeptidase A (APA) on hypertension in pregnant spontaneously hypertensive rats (SHRs).
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 2009 |
Angiotensin II receptor blocker candesartan cilexetil, but not hydralazine hydrochloride, protects against mouse cardiac enlargement resulting from undernutrition in utero.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Caloric Restriction; Cardiomegaly; Disease Models, Anim | 2009 |
Effects of pregnancy, hypertension and nitric oxide inhibition on rat uterine artery myogenic reactivity.
Topics: Animals; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Female; Hydralazine; Hypertensio | 2010 |
Electrical velocimetry follows the hemodynamics of drug therapy and aortocaval compression in preeclampsia.
Topics: Adult; Antihypertensive Agents; Aorta; Blood Pressure; Cardiac Output; Cardiography, Impedance; Fema | 2011 |
Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
Topics: Algorithms; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; L | 2011 |
Effect of intravenous hydralazine infusion on maternal plasma nitric oxide levels in gestations complicated with severe preeclampsia: a pilot study.
Topics: Adolescent; Adult; Antihypertensive Agents; Birth Weight; Blood Pressure; Female; Humans; Hydralazin | 2012 |
Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensiv | 2002 |
The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dopamine; Dose-Response Relation | 2003 |
Interleukin-18 in the plasma of women with preeclampsia.
Topics: Adult; Antihypertensive Agents; Betamethasone; Case-Control Studies; Drug Therapy, Combination; Fema | 2003 |
Continuous systolic blood pressure monitoring by the difference in electrocardiogram and pulse oximetry in near-term, exteriorized goat fetuses.
Topics: Animals; Blood Gas Analysis; Blood Pressure Determination; Electrocardiography; Female; Fetal Monito | 2003 |
The place of the hydrazinophthalazine and thiophanium complications of pregnancy.
Topics: Hydralazine; Hypertension; Pregnancy; Sympatholytics | 1952 |
Fatal reaction to 1-hydrazinophthalazine (apresoline).
Topics: Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Sympatholytics | 1953 |
Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.
Topics: Administration, Intravenous; Female; Hemodynamics; Hydralazine; Pre-Eclampsia; Pregnancy; Sympatholy | 1953 |
Effects of apresoline, veratrum alkaloids, high spinal anesthesia, and arfonad on renal hemodynamics of pregnant patients with toxemia and essential hypertension.
Topics: Anesthesia, Spinal; Essential Hypertension; Female; Hemodynamics; Hydralazine; Hypertension; Pre-Ecl | 1953 |
Cerebral circulation and metabolism in toxemia of pregnancy; observations on the effects of veratrum viride and apresoline (1-hydrazinophthalazine).
Topics: Brain; Cerebrovascular Circulation; Female; Hydralazine; Pre-Eclampsia; Pregnancy; Sympatholytics; V | 1953 |
Apresoline (l-hydrazinophthalazine) in the experimental eclampsia-like syndrome and related aspects of water metabolism.
Topics: Eclampsia; Edema; Female; Hydralazine; Kidney; Pregnancy; Sympatholytics; Syndrome; Water | 1953 |
[Clinico-experimental research on circulatory action of some hydrazinophthalazine derivatives with hypotensive action].
Topics: Antihypertensive Agents; Female; Hydralazine; Hypertension; Hypotension; Pregnancy; Pregnancy Compli | 1953 |
Experience with hydrazinophthalazine in hypertensive states of pregnancy.
Topics: Female; Hydralazine; Hypertension; Pregnancy; Pregnancy Complications; Sympatholytics | 1954 |
The use of 1-hydrazinophthalazine (apresoline) in the management of hypertension appearing early in pregnancy.
Topics: Disease Management; Female; Hydralazine; Hypertension; Pregnancy; Pregnancy Complications; Sympathol | 1954 |
Apresoline (hydralazine hydrochloride) and its use in cases of hypertensive pregnancy.
Topics: Eclampsia; Female; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy; Sympatholytics | 1954 |
[Trial of hydrazinophthalazine therapy of hypertension in two cases of grave eclampsia].
Topics: Eclampsia; Female; Hydralazine; Hypertension; Pregnancy; Sympatholytics | 1953 |
The clinical use of apresoline in the toxemias of pregnancy: a preliminary report.
Topics: Female; Hydralazine; Pre-Eclampsia; Pregnancy; Sympatholytics; Toxemia | 1954 |
[Experimental hydralazine therapy of hypertension in two cases of severe eclampsia].
Topics: Eclampsia; Female; Hydralazine; Hypertension; Pregnancy; Sympatholytics; Therapies, Investigational | 1954 |
Continuing vasodilator infusion therapy; utilization of a blend of 1-hydrazinophthalazine (apresoline) and cryptenamine (unitensen) in toxemia of pregnancy.
Topics: Female; Hydralazine; Pre-Eclampsia; Pregnancy; Protoveratrines; Sympatholytics; Vasodilator Agents; | 1954 |
Further experience with apresoline in toxemia and hypertension of pregnancy.
Topics: Female; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Sepsis; Sympat | 1956 |
[Hydrazinophthalazine compounds in the treatment of hypertension in obstetrics and gynecology].
Topics: Female; Gynecology; Humans; Hydralazine; Hypertension; Kidney Diseases; Obstetrics; Pregnancy; Pregn | 1956 |
[Treatment of gestosis by new hypotensive drugs].
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Reserpine; Sympathol | 1957 |
Antihypertension therapy in toxemia of pregnancy; a 30 month progress report.
Topics: Female; Humans; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy; Research Report; Veratrum Alkal | 1957 |
Hypotensive drugs in the management of toxemia of pregnancy.
Topics: Antihypertensive Agents; Disease Management; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; | 1957 |
[Nepresol therapy of eclampsia & pre-eclampsia].
Topics: Eclampsia; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Sympatholytics | 1957 |
A clinical trial of intravenous apresoline in the management of toxaemia of late pregnancy.
Topics: Bacterial Infections; Disease Management; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Sep | 1958 |
[Anuria after or caused by obstetrical collapse treated with a nepresol-hibernalpethidine preparation].
Topics: Anuria; Chlorpromazine; Female; Humans; Hydralazine; Meperidine; Obstetric Labor Complications; Obst | 1958 |
Antihypertensive drugs in toxemia: a practical integrated plan of management.
Topics: Antihypertensive Agents; Bacterial Infections; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy | 1959 |
Routine use of intramuscular apresoline for the prevention of eclampsia.
Topics: Biomedical Research; Eclampsia; Female; Humans; Hydralazine; Injections, Intramuscular; Pregnancy | 1959 |
[Can infant mortality in late pregnancy toxemia be reduced by treatment with hypotensive drugs].
Topics: Antihypertensive Agents; Bacterial Infections; Female; Hydralazine; Infant Mortality; Pre-Eclampsia; | 1959 |
Treatment of severe toxemia of pregnancy with intravenous magnesium sulfate and apresoline.
Topics: Administration, Intravenous; Female; Humans; Hydralazine; Magnesium Sulfate; Pre-Eclampsia; Pregnanc | 1959 |
[On the treatment of pre-eclampsia with Esidrex and Adelphan-Esidrex].
Topics: Chlorothiazide; Drug Combinations; Female; Hydralazine; Hydrazines; Hydrochlorothiazide; Pre-Eclamps | 1961 |
Peripheral vascular response to hydralazine in toxemia of pregnancy.
Topics: Blood Vessels; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy | 1961 |
[On the treatment of eclampsia].
Topics: Eclampsia; Female; Hibernation; Humans; Hydralazine; Hypothermia, Induced; Pregnancy; Rauwolfia | 1962 |
PRE-ECLAMPTIC TOXAEMIA OF PREGNANCY AND THE USE OF ANTI-HYPERTENSIVE DRUGS.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hydrochlorothiazide; Pre-Eclampsia; Pregnancy; | 1963 |
A SYSTEMATIC APPROACH TO THE THERAPY OF SEVERE PRE-ECLAMPSIA AND ECLAMPSIA.
Topics: Abortion, Therapeutic; Anesthesia; Anesthesia, Obstetrical; Anticonvulsants; Antihypertensive Agents | 1963 |
A THIRTY YEAR EVALUATION OF LUPUS ERYTHEMATOSUS.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antitubercular Agents; Appetite Depressants; Chloroquine; | 1964 |
THE CONTINUING PROBLEM OF ECLAMPSIA.
Topics: Amobarbital; Antihypertensive Agents; Cesarean Section; Eclampsia; Female; Humans; Hydralazine; Hype | 1964 |
[MEDICAL TREATMENT OF HYPERTENSIVE CRISES].
Topics: Diuretics; Female; Ganglionic Blockers; Glomerulonephritis; Hexamethonium Compounds; Humans; Hydrala | 1964 |
RAPID STABILIZATION BY HYPOTENSIVE DRUGS FOLLOWED BY EARLY DELIVERY IN ANTEPARTUM ECLAMPSIA TREATMENT.
Topics: Adolescent; Antihypertensive Agents; Cesarean Section; Delivery, Obstetric; Eclampsia; Female; Human | 1964 |
[THERAPEUTICS OF ARTERIAL HYPERTENSION IN PREGNANCY].
Topics: Female; Guanethidine; Hibernation; Humans; Hydralazine; Hypertension; Hypothermia, Induced; Maternal | 1964 |
CESAREAN SECTION IN THE ECLAMPTIC PATIENT ON ANTIHYPERTENSIVE THERAPY: A REVIEW OF FOURTEEN CASES.
Topics: Adolescent; Anesthesia; Antihypertensive Agents; Cesarean Section; Child; Drug Therapy; Eclampsia; F | 1964 |
THE NEPHROTIC SYNDROME DUE TO PRE-ECLAMPTIC NEPHROPATHY; REPORT OF A CASE.
Topics: Blood Pressure; Blood Pressure Determination; Drug Therapy; Female; Humans; Hydralazine; Kidney Dise | 1964 |
[TREATMENT OF PREGNANCY TOXICOSIS WITH ADELPHIN-ESIDREX-K].
Topics: Drug Therapy; Female; Hydralazine; Hydrochlorothiazide; Pre-Eclampsia; Pregnancy; Reserpine | 1964 |
EFFECT OF CERTAIN DRUGS ON PERFUSED HUMAN PLACENTA. IV. DETECTION OF SPECIFIC RECEPTOR SITES.
Topics: Epinephrine; Female; Histamine; Humans; Hydralazine; Norepinephrine; Perfusion; Pharmacology; Phento | 1964 |
PROGRAM FOR TOXEMIA CONTROL: STUDY OF 551 CASES.
Topics: Anticonvulsants; Delivery, Obstetric; Drug Therapy; Eclampsia; Female; Humans; Hydralazine; Pre-Ecla | 1965 |
Hexamethonium chloride and apresoline in toxemia of pregnancy; a preliminary report.
Topics: Female; Hexamethonium; Hydralazine; Muscle Relaxants, Central; Pre-Eclampsia; Pregnancy; Sympatholyt | 1955 |
Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome.
Topics: Adolescent; Adult; Alanine Transaminase; Antihypertensive Agents; Aspartate Aminotransferases; Betam | 2003 |
Late postpartum eclampsia coincident with postdural puncture headache: a case report.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anticonvulsants; Antihypertensive Agents; Bloo | 2003 |
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
Topics: Adult; Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Fetus; Humans; Hydralazine | 2004 |
The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units.
Topics: Antihypertensive Agents; Female; Hospital Units; Humans; Hydralazine; Hypertension, Pregnancy-Induce | 2004 |
Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy.
Topics: Antihypertensive Agents; Cell Culture Techniques; Cells, Cultured; Clonidine; Culture Media, Conditi | 2006 |
Presentation and outcome of eclampsia at a Nigerian university hospital.
Topics: Adolescent; Adult; Diazepam; Eclampsia; Female; Hospitals, University; Humans; Hydralazine; Incidenc | 2007 |
Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Eclampsia; Fema | 2008 |
Medical grand rounds from the University of Alabama Medical Center.
Topics: Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Pregnancy in Diabetics | 1967 |
[Antihypertensive therapy in pregnancy].
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Clonidine; Female; Humans; Hydralazine; Hydro | 1982 |
Adrenergic beta-receptor blockers in hypertension of pregnancy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Birth Weight; Blood Pressure; Delivery, Obstetric; F | 1982 |
Drug selection in the treatment of pregnancy hypertension. A survey.
Topics: Adrenal Glands; Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Card | 1984 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growt | 1984 |
[Influence of blood pressure control on delivery in pregnant rats in a warm environment].
Topics: Animals; Blood Pressure; Etilefrine; Female; Hot Temperature; Hydralazine; Labor, Obstetric; Pregnan | 1984 |
Therapeutic regime on pregnancy induced hypertension.
Topics: Dextrans; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; I | 1982 |
[Forum on hypertension. Part 8. Hypertension management in pregnancy].
Topics: Antihypertensive Agents; Dihydralazine; Diuretics; Female; Humans; Hydralazine; Hypertension; Methyl | 1981 |
Cutaneous manifestations of hydrallazine toxicity.
Topics: Adult; Drug Eruptions; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Pregnancy; Pregna | 1980 |
[Hemodynamic response to hydralazine in pregnant women with hypertension].
Topics: Female; Hemodynamics; Humans; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complic | 1984 |
Longitudinal evaluation of hemodynamic changes in eclampsia.
Topics: Adolescent; Adult; Cardiac Output; Delivery, Obstetric; Diuresis; Eclampsia; Female; Fluid Therapy; | 1984 |
Disposition of the adrenergic blocker metoprolol in the late-pregnant woman, the amniotic fluid, the cord blood and the neonate.
Topics: Amniotic Fluid; Drug Therapy, Combination; Female; Fetal Blood; Humans; Hydralazine; Hypertension; I | 1984 |
Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy.
Topics: Blood Pressure; Dihydralazine; Female; Heart Rate; Humans; Hydralazine; Hypertension; Placenta; Pre- | 1983 |
[Acute liver disease during treatment of severe preeclampsia].
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Hydralazine; Liver Dis | 1983 |
[Eclampsia: critical considerations on its therapy].
Topics: Anesthesia, Epidural; Benzothiadiazines; Diuresis; Eclampsia; Female; Humans; Hydralazine; Magnesium | 1983 |
The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases.
Topics: Analgesics; Anesthetics; Delivery, Obstetric; Eclampsia; Female; Fetal Death; Fluid Therapy; Humans; | 1984 |
Cortical blindness as a complication of eclampsia.
Topics: Adult; Blindness; Eclampsia; Female; Humans; Hydralazine; Hypertension; Labor, Induced; Oxytocin; Pr | 1984 |
Intrapartum treatment of preeclamptic hypertension by ketanserin--a serotonin receptor antagonist.
Topics: Adult; Antihypertensive Agents; Delivery, Obstetric; Female; Humans; Hydralazine; Hypertension; Infa | 1984 |
Shock after phenothiazine administration in a pregnant patient with a pheochromocytoma. A case report and literature review.
Topics: Adrenal Gland Neoplasms; Adult; Diagnosis, Differential; Female; Humans; Hydralazine; Hypertension; | 1983 |
Antihypertensive therapy during pregnancy.
Topics: Antihypertensive Agents; Diuretics; Female; Humans; Hydralazine; Hypertension; Methyldopa; Pregnancy | 1983 |
Severe consequence of hypertension in pregnancy.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hydralazine; Hypertension; Pre-Eclampsia; Pr | 1983 |
Eclampsia: treatment and referral.
Topics: Adolescent; Adult; Delivery, Obstetric; Eclampsia; Female; Humans; Hydralazine; Infant Mortality; In | 1982 |
[Significance & treatment of abnormal blood viscosities in pre-eclamptic patients (author's transl)].
Topics: Adenosine Triphosphate; Adult; Blood Viscosity; Blood Volume Determination; Erythrocyte Count; Femal | 1982 |
The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy.
Topics: Blood Pressure; Depression, Chemical; Dihydralazine; Female; Fetal Growth Retardation; Fetal Heart; | 1982 |
Transplacental passage and breast milk concentrations of hydralazine.
Topics: Adult; Breast Feeding; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Maternal-Fetal Ex | 1982 |
Adverse effects of a combination of diazoxide and hydrallazine therapy.
Topics: Adolescent; Adult; Blood Pressure; Diazoxide; Drug Interactions; Drug Therapy, Combination; Female; | 1981 |
Preeclampsia and eclampsia.
Topics: Adult; Diazoxide; Eclampsia; Female; Humans; Hydralazine; Magnesium Sulfate; Pre-Eclampsia; Pregnanc | 1981 |
Hope in primary pulmonary hypertension.
Topics: Child; Diazoxide; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Pregnancy; Tim | 1980 |
Propranolol and hydrallazine in the management of essential hypertension in pregnancy.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Hypoglycemia; Infant, N | 1980 |
Effect of dihydralazine on the fetus in the treatment of maternal hypertension.
Topics: Birth Weight; Dihydralazine; Female; Fetal Death; Fetal Growth Retardation; Fetal Heart; Fetal Monit | 1980 |
Hydralazine-induced neonatal thrombocytopenia.
Topics: Adult; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Infant, Newborn, Diseases; Pre-Ec | 1980 |
Blood pressure response in hypertensive pregnancies treated with cortisol.
Topics: Adolescent; Adult; Blood Pressure; Drug Therapy, Combination; Ethanol; Female; Humans; Hydralazine; | 1980 |
Primary pulmonary hypertension: new approaches to therapy.
Topics: Diazoxide; Female; Humans; Hydralazine; Hypertension, Pulmonary; Phentolamine; Pregnancy | 1980 |
Depressed sodium-calcium exchange in human umbilical arteries from women with preeclampsia.
Topics: Adult; Blood Pressure; Calcium; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Sodium; Umbil | 1995 |
Regulation of lysyl oxidase mRNA in dermal fibroblasts from normal donors and patients with inherited connective tissue disorders.
Topics: Aminopropionitrile; Ascorbic Acid; Bleomycin; Cell Line; Collagen; Connective Tissue Diseases; DNA P | 1994 |
Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation.
Topics: Adolescent; Adult; Amino Acid Oxidoreductases; Aminoquinolines; Arginine; Blood Pressure; Dose-Respo | 1994 |
Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia.
Topics: Female; Humans; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as | 1995 |
Pre-eclampsia and gestational age differently alter binding of endothelin-1 to placental and trophoblast membrane preparations.
Topics: Adult; Cell Membrane; Endothelins; Female; Humans; Hydralazine; Placenta; Pre-Eclampsia; Pregnancy; | 1995 |
Pre-eclampsia and hypertension in pregnancy.
Topics: Antihypertensive Agents; Contraindications; Female; Guidelines as Topic; Hospitalization; Humans; Hy | 1994 |
Human umbilical vessels: responses to agents frequently used in obstetric patients.
Topics: Analysis of Variance; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hydralazine; In Vi | 1995 |
Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia.
Topics: Female; Humans; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy | 1995 |
Hydralazine injection still available.
Topics: Female; Humans; Hydralazine; Injections, Intravenous; Pre-Eclampsia; Pregnancy; United States | 1994 |
Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia.
Topics: Adult; Blood Pressure; Clinical Protocols; Female; Gestational Age; Humans; Hydralazine; Hydrogen-Io | 1994 |
Effects of hydralazine on pregnant rats and their fetuses.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Birth Weight; Dose-Response Relationship | 1993 |
Periarterial lidocaine/hydralazine aids arterial catheter insertion in patients with preeclampsia.
Topics: Arteries; Catheterization, Peripheral; Female; Humans; Hydralazine; Lidocaine; Pre-Eclampsia; Pregna | 1993 |
Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
Topics: Adolescent; Adult; Female; Fetal Hypoxia; Hemodynamics; Humans; Hydralazine; Infant, Newborn; Labeta | 1993 |
Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: effects of hydralazine.
Topics: Adult; Arginine; Birth Weight; Blood Pressure; Cyclic GMP; Female; Humans; Hydralazine; Nitric Oxide | 1996 |
Low-dose dopamine in treating acute renal failure caused by preeclampsia.
Topics: Acute Kidney Injury; Adult; Antihypertensive Agents; Blood Urea Nitrogen; Cesarean Section; Creatini | 1996 |
Fos expression in brain stem nuclei of pregnant rats after hydralazine-induced hypotension.
Topics: Animals; Antihypertensive Agents; Brain Stem; Cerebral Ventricles; Female; Hydralazine; Hypotension; | 1999 |
Anticardiolipin antibodies and the severity of preeclampsia-eclampsia.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Anticardiolipin; Antihypertensive Agents; Cross-Sectiona | 1999 |
Ex vivo human placental transfer and the vasoactive properties of hydralazine.
Topics: Chromatography, High Pressure Liquid; Female; Fetal Blood; Humans; Hydralazine; In Vitro Techniques; | 2000 |
Pre-eclampsia is associated with marked alterations in sleep architecture.
Topics: Adult; Antihypertensive Agents; Clonidine; Electroencephalography; Electrooculography; Female; Human | 2000 |
Bradykinin B2 null mice are prone to renal dysplasia: gene-environment interactions in kidney development.
Topics: Angiotensinogen; Animals; Animals, Newborn; Antihypertensive Agents; Aquaporin 2; Aquaporin 6; Aquap | 2000 |
Successful pregnancy in a patient with polycystic kidney disease and advanced renal failure without prophylactic dialysis.
Topics: Acute Kidney Injury; Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Rena | 2001 |
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; | 2001 |
Antihypertensive treatment decreased serum leptin levels in severe preeclampsia during pregnancy.
Topics: Adult; Antihypertensive Agents; Body Mass Index; Enzyme-Linked Immunosorbent Assay; Female; Gestatio | 2001 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; H | 1978 |
Review: the significance and management of raised blood pressure in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Chlormethiazole; Clonidine; Diazepam; D | 1979 |
The metabolic clearance rate of dehydroisoandrosterone sulfate. IV. Acute effects of induced hypertension, hypotension, and naturesis in normal and hypertensive pregnancies.
Topics: Adult; Angiotensin II; Blood Pressure; Dehydroepiandrosterone; Female; Furosemide; Humans; Hydralazi | 1976 |
Evaluation of a program of bed rest in the treatment of chronic hypertension in pregnancy.
Topics: Bed Rest; Birth Weight; Chronic Disease; Female; Fetal Death; Humans; Hydralazine; Hypertension; Inf | 1979 |
Hypertensive emergencies.
Topics: Adrenal Gland Neoplasms; Angiotensin II; Animals; Aortic Aneurysm; Aortic Dissection; Brain Diseases | 1979 |
Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension.
Topics: Adult; Antihypertensive Agents; Chronic Disease; Female; Fetal Growth Retardation; Fetus; Growth; Hu | 1979 |
Hypotensive sequelae of diazoxide and hydralazine therapy.
Topics: Adult; Diazoxide; Drug Synergism; Female; Humans; Hydralazine; Hypotension; Male; Middle Aged; Pregn | 1977 |
Glucocorticoid therapy for the induction of pulmonary maturity in severely hypertensive gravid women.
Topics: Betamethasone; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Labor, Induced; Pre-Eclam | 1979 |
Clinical management of pregnancy-induced hypertension.
Topics: Age Factors; Ambulatory Care; Delivery, Obstetric; Female; Gestational Age; Hospitalization; Humans; | 1978 |
Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pregnancy; Pregnancy Co | 1978 |
Nonsurgical management of renovascular hypertension in the neonate.
Topics: Adult; Antihypertensive Agents; Diazoxide; Diuretics; Female; Humans; Hydralazine; Hypertension, Ren | 1978 |
Pre-eclampsia and eclampsia.
Topics: Anesthesia, Obstetrical; Bed Rest; Cesarean Section; Delivery, Obstetric; Eclampsia; Female; Humans; | 1978 |
Management of severe preeclampsia and eclampsia.
Topics: Adolescent; Adult; Delivery, Obstetric; Eclampsia; Female; Humans; Hydralazine; Magnesium Sulfate; P | 1978 |
Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy.
Topics: Apgar Score; Drug Evaluation; Drug Therapy, Combination; Female; Fetal Growth Retardation; Fetus; Hu | 1978 |
The management of severe pre-eclampsia and eclampsia.
Topics: Chlormethiazole; Delivery, Obstetric; Diazepam; Diuretics; Eclampsia; Female; Humans; Hydralazine; H | 1977 |
Drugs used in the management of toxemia of pregnancy.
Topics: Anticonvulsants; Antihypertensive Agents; Barbiturates; Benzothiadiazines; Blood Volume; Diazepam; D | 1977 |
Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes.
Topics: Animals; Cardiac Output; Female; Ferricyanides; Heart Rate; Hydralazine; Hypertension; Nitroprusside | 1977 |
Management of eclampsia.
Topics: Adult; Chlormethiazole; Clonidine; Eclampsia; Female; Humans; Hydralazine; Pregnancy | 1976 |
Uteroplacental hemodynamic response to antihypertensive drugs in hypertensive pregnant sheep.
Topics: Animals; Blood Pressure; Female; Heart Rate; Hydralazine; Hypertension, Renal; Placenta; Pregnancy; | 1976 |
Standardized treatment of 154 consecutive cases of eclampsia.
Topics: Abruptio Placentae; Anesthesia; Bradycardia; Delivery, Obstetric; Diuretics; Eclampsia; Female; Feta | 1975 |
The treatment of gestational hypertension.
Topics: Antihypertensive Agents; Chronic Disease; Diazoxide; Female; Humans; Hydralazine; Hypertension; Hype | 1975 |
Effect of treatment on longevity in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Chlorothiazide; Female; Hydralazine; Hypertension; Longevity; | 1975 |
[Reduction of the arterial pressure with the help of dihydralazin in late toxemia of pregnancy].
Topics: Blood Pressure; Dihydralazine; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy | 1975 |
Differential effects of intravenous hydralazine on myoendometrial and placental blood flow in hypertensive pregnant ewes.
Topics: Adrenal Glands; Angiotensin II; Animals; Endometrium; Female; Hydralazine; Hypertension; Injections, | 1992 |
[Antepartum CTG: extreme growth retardation and choice of delivery time].
Topics: Adult; Cardiotocography; Delivery, Obstetric; Female; Fetal Growth Retardation; Gestational Age; Hum | 1992 |
Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe.
Topics: Animals; Blood Pressure; Catecholamines; Cocaine; Female; Fetus; Heart Rate; Hydralazine; Hypertensi | 1992 |
How do perinatologists manage preeclampsia?
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure Determination; Data Collection; Delivery, Obstetr | 1991 |
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
Topics: Female; Heart Rate, Fetal; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pr | 1991 |
Effects of vasodilators on isolated human uteroplacental arteries.
Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitren | 1991 |
Should continuous hydralazine infusions be utilized in severe pregnancy-induced hypertension?
Topics: Apgar Score; Blood Pressure; Female; Fetal Distress; Hemodynamics; Humans; Hydralazine; Infant, Newb | 1991 |
Cocaine intoxication associated with abruptio placentae.
Topics: Abruptio Placentae; Adult; Cocaine; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; Pr | 1991 |
Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors.
Topics: Adult; Birth Weight; Cerebral Hemorrhage; Cesarean Section; Female; Fetal Growth Retardation; Gestat | 1989 |
Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report.
Topics: Adult; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Lupus Vulgaris; Pregnancy; Pregna | 1989 |
Implications of sino-aortic baroreceptor reflex dysfunction in severe preeclampsia.
Topics: Adult; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hydralazine; Pre-Ec | 1989 |
[Hypertension in pregnancy: proposed monitoring and therapy].
Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; H | 1985 |
Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring.
Topics: Atenolol; Cardiac Output; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Pregnancy; Pregna | 1989 |
Fetal premature atrial contractions associated with hydralazine.
Topics: Adult; Arrhythmias, Cardiac; Blood Pressure; Echocardiography; Female; Fetal Diseases; Heart Rate; H | 1989 |
Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes.
Topics: Carrier Proteins; Cations, Monovalent; Desipramine; Female; Humans; Hydralazine; Imipramine; Kinetic | 1989 |
Elevated blood pressure during pregnancy.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Me | 1986 |
The effect of hydralazine on steady-state plasma concentrations of metoprolol in pregnant hypertensive women.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Meto | 1988 |
Dihydralazine and the uteroplacental blood flow.
Topics: Dihydralazine; Female; Humans; Hydralazine; Hypertension; Placenta; Pregnancy; Pregnancy Complicatio | 1988 |
Hypertensive crisis in L & D.
Topics: Adult; Critical Care; Diazoxide; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; Nitro | 1988 |
Comparison of nitroprusside and hydralazine in isolated uterine arteries from pregnant and nonpregnant patients.
Topics: Arteries; Female; Ferricyanides; Humans; Hydralazine; In Vitro Techniques; Muscle Contraction; Muscl | 1988 |
Effect of the antihypertensive drug hydralazine on mineral metabolism in the rat.
Topics: Animals; Copper; Dose-Response Relationship, Drug; Female; Hydralazine; Iron; Manganese; Minerals; P | 1988 |
Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension.
Topics: Animals; Animals, Newborn; Blood Pressure; Blood Vessels; Female; Hydralazine; Muscle, Smooth, Vascu | 1988 |
Chronic measurement, using a Doppler probe, of uterine artery flow in the gravid guinea-pig.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Epinephrine; Female; Guinea Pigs; Hydralazine; Models, | 1986 |
Cardiovascular actions of dihydralazine as modified by dietary linoleic acid.
Topics: Animals; Aorta, Abdominal; Aspirin; Blood Pressure; Dietary Fats; Dihydralazine; Epoprostenol; Fatty | 1986 |
The use of dihydralazine infusion in the management of severe hypertension in pregnancy.
Topics: Adult; Dihydralazine; Female; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Pregnancy; | 1986 |
The management of severe preeclampsia with intravenous magnesium sulphate, hydralazine and central venous catheterization.
Topics: Acute Disease; Catheterization, Central Venous; Drug Therapy, Combination; Female; Humans; Hydralazi | 1987 |
Fetal distress after hydralazine therapy for severe pregnancy-induced hypertension.
Topics: Acute Disease; Cesarean Section; Eclampsia; Female; Fetal Distress; Gestational Age; Humans; Hydrala | 1986 |
Effect of antihypertensive drugs on catechol-O-methyltransferase and monoamine oxidase activity in human term placental explants.
Topics: Antihypertensive Agents; Catechol O-Methyltransferase; Dose-Response Relationship, Drug; Female; Hum | 1986 |
[Studies of heart function using apex cardiography in pregnancy-induced hypertension before and following therapy with dihydralazine sulfate].
Topics: Blood Pressure; Dihydralazine; Female; Hemodynamics; Humans; Hydralazine; Kinetocardiography; Myocar | 1986 |
Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
Topics: Adult; Blood Pressure; Blood Volume; Cardiac Output; Chorionic Villi; Dihydralazine; Female; Furosem | 1986 |
Beta-blockade-vasodilator therapy in peripartum cardiomyopathy.
Topics: Adolescent; Cardiomyopathy, Dilated; Female; Humans; Hydralazine; Pregnancy; Propranolol | 1986 |
Fetal distress with hydralazine.
Topics: Female; Fetal Distress; Humans; Hydralazine; Pregnancy | 1987 |
The effect of hydralazine on placental perfusion in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Female; Hydralazine; Hypertension; Perfusion; Placenta; Pregnancy; | 1987 |
Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids.
Topics: 6-Ketoprostaglandin F1 alpha; Blood Pressure; Dihydralazine; Female; Fetal Heart; Humans; Hydralazin | 1985 |
Studies on the kinetics and distribution of dihydralazine in pregnancy.
Topics: Administration, Oral; Adolescent; Adult; Amniotic Fluid; Dihydralazine; Female; Fetal Blood; Humans; | 1986 |
Severe preeclampsia with persistent postpartum hemolysis and thrombocytopenia treated by plasmapheresis.
Topics: Adult; Anemia, Hemolytic; Aspartate Aminotransferases; Blood Transfusion; Blood Urea Nitrogen; Femal | 1985 |
Diagnosis and management of malignant hypertension.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Malignant; Kidney Function Tests | 1985 |
Plasma prolactin concentrations and pregnancy-induced hypertension.
Topics: Adult; Apgar Score; Birth Weight; Circadian Rhythm; Female; Gestational Age; Humans; Hydralazine; Hy | 1985 |
Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester.
Topics: Administration, Oral; Antihypertensive Agents; Bed Rest; Birth Weight; Delivery, Obstetric; Diuretic | 1985 |
Hypertension in pregnancy. A study of 142 women presenting before 32 weeks' gestation.
Topics: Antihypertensive Agents; Clonidine; Diazoxide; Female; Humans; Hydralazine; Hypertension; Infant Mor | 1985 |
Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
Topics: Adult; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Hydralazine; Hypertension; Pregna | 1985 |
Management of autonomic hyperreflexia associated with a low thoracic spinal cord lesion.
Topics: Adult; Autonomic Nervous System Diseases; Cesarean Section; Female; Humans; Hydralazine; Obstetric L | 1985 |
Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
Topics: Blood Pressure; Body Surface Area; Cardiac Output; Echocardiography; Female; Hemodynamics; Humans; H | 1985 |
Management of severe hypertension.
Topics: Benzothiadiazines; Blood Pressure; Clonidine; Diazoxide; Diet, Sodium-Restricted; Disseminated Intra | 1973 |
Periodic dialysis in terminal uremia.
Topics: Adolescent; Adult; Anemia; Arthritis; Child; Female; Gastrointestinal Hemorrhage; Glaucoma; Glomerul | 1967 |
Effect of certain drugs on perfused human placenta. 8. Angiotensin-II antagonists.
Topics: Acetates; Angiotensin II; Atropine; Blood Pressure Determination; Cobalt; Cocaine; Cyproheptadine; D | 1968 |
Dynamics of uterine circulation in pregnant and nonpregnant sheep.
Topics: Angiotensin II; Animals; Blood Pressure; Female; Homeostasis; Hydralazine; Injections, Intra-Arteria | 1970 |
Effect of certain drugs on perfused human placenta. IX. Mode of action of angiotensin.
Topics: Angiotensin II; Blood Vessels; Constriction; Dipyridamole; Ethanolamines; Female; Humans; Hydralazin | 1969 |
A critical survey of drugs used in the treatment of hypertensive crises of pregnancy.
Topics: Anesthesia, Conduction; Anesthesia, Obstetrical; Barbiturates; Chlormethiazole; Clonidine; Diazepam; | 1974 |
[Pregnancy toxemia. Mechanism, prevention and treatment].
Topics: Blood Coagulation Disorders; Diet, Sodium-Restricted; Diuretics; Eclampsia; Edema; Female; Hospitali | 1974 |
Intravenous chlormethiazole in the management of severe pre-eclampsia.
Topics: Adolescent; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Apgar Score; Chlormethiazole; Chlo | 1973 |
The use of diazepam and hydrallazine in the treatment of severe pre-eclampsia.
Topics: Adult; Blood Pressure; Diazepam; Ethanol; Female; Gestational Age; Humans; Hydralazine; Hypothermia; | 1972 |
The management of hypertension during pregnancy.
Topics: Adolescent; Adult; Blood Pressure; Clinical Laboratory Techniques; Diagnosis, Differential; Dihydrox | 1972 |
[Therapy of EPH gestosis].
Topics: Chlorthalidone; Diazepam; Diet Therapy; Eclampsia; Edema; Female; Furosemide; Guanethidine; Humans; | 1973 |
Diuretic-hypotensive therapy and fetal prognosis in toxaemia of pregnancy. 1. Fetal prognosis in 705 selected cases.
Topics: Acetazolamide; Ammonium Chloride; Antihypertensive Agents; Barbiturates; Birth Weight; Chlorothiazid | 1973 |
Active management of severe pre-eclampsia.
Topics: Adult; Animals; Apgar Score; Birth Weight; Delivery, Obstetric; Diazepam; Female; Fetal Death; Human | 1973 |
Galactorrhea and Parkinson-like syndrome: an adverse effect of alpha-methyldopa.
Topics: Adolescent; Amenorrhea; Female; Glomerulonephritis; Humans; Hydralazine; Hypertension; Kidney Transp | 1970 |
Effect of toxemia therapy on uterine dynamics.
Topics: Amniotic Fluid; Animals; Arteries; Blood Pressure; Eclampsia; Female; Haplorhini; Humans; Hydralazin | 1969 |
[Therapy of pregnancy toxemias (EPH-gestosis, preeclampsia)].
Topics: Blood Pressure Determination; Chlorpromazine; Dextrans; Diazepam; Diet Therapy; Edema; Female; Human | 1972 |
[Indication for cesarean section: pregnancy toxemia].
Topics: Adult; Cesarean Section; Chlorpromazine; Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Rese | 1972 |
Coexistent trophoblastic tumor and viable pregnancy.
Topics: Adult; Choriocarcinoma; Chorionic Gonadotropin; Female; Humans; Hydatidiform Mole; Hydralazine; Hype | 1971 |
[On a new hypotensive pharmacological association in pregnancy with hypertension].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbamates; Creatinine; Electrolytes; Female; Humans | 1971 |
Clinical and laboratory observations on eclampsia.
Topics: Blood Chemical Analysis; Blood Volume Determination; Cesarean Section; Delivery, Obstetric; Eclampsi | 1967 |
[Cerebral anoxia during treatment of severe toxemias with hypotensive infusion].
Topics: Adult; Chlorpromazine; Female; Humans; Hydralazine; Hypoxia, Brain; Pre-Eclampsia; Pregnancy | 1969 |
Effects of hydralazine on uteroplacental and fetal circulations.
Topics: Animals; Animals, Newborn; Arteries; Blood Pressure; Carbon Dioxide; Female; Fetus; Heart Rate; Hydr | 1970 |
Pharmacogenetics.
Topics: Aged; Cortisone; Enzyme Induction; Female; Glaucoma; Humans; Hydralazine; Intraocular Pressure; Ison | 1970 |
[Therapy of hypertension].
Topics: Adrenal Gland Neoplasms; Aniline Compounds; Antihypertensive Agents; Diuretics; Female; Guanethidine | 1971 |
Aggressive toxemia management (preeclampsia and eclampsia).
Topics: Antihypertensive Agents; Cesarean Section; Female; Humans; Hydralazine; Magnesium Sulfate; Pre-Eclam | 1969 |
Essential hypertension complicating pregnancy: Factors affecting the fetal mortality.
Topics: Adult; Female; Fetal Death; Humans; Hydralazine; Hypertension; Middle Aged; Pregnancy; Pregnancy Com | 1966 |
[How can the difficulties in the antihypertensive therapy of prolonged pregnancy be prevented?].
Topics: Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Phytotherapy; Plants, Med | 1966 |